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Substantial genetic liability is shared across psychiatric disorders but less is known about risk 
variants that are specific to a given disorder. We used multi-trait conditional and joint 
analysis (mtCOJO) to adjust GWAS summary statistics of one disorder for the effects of 
genetically correlated traits to identify putative disorder-specific SNP associations. We 
applied mtCOJO to summary statistics for five psychiatric disorders from the Psychiatric 
Genomics Consortium – schizophrenia (SCZ), bipolar disorder (BIP), major depression 
(MD), attention-deficit hyperactivity disorder (ADHD) and autism (AUT). Most genome-
wide significant variants for these disorders had evidence of pleiotropy (i.e., impact on 
multiple psychiatric disorders) and hence have reduced mtCOJO conditional effect sizes. 
However, subsets of genome-wide significant variants had larger conditional effect sizes 
consistent with disorder-specific effects: 15 of 130 genome-wide significant variants for 
schizophrenia, 5 of 40 for major depression, 3 of 11 for ADHD and 1 of 2 for autism. We 
show that decreased expression of VPS29 in the brain may increase risk to SCZ only and 
increased expression of CSE1L is associated with SCZ and MD, but not with BIP. Likewise, 
decreased expression of PCDHA7 in the brain is linked to increased risk of MD but decreased 























Pervasive sharing of genetic risk factors between common psychiatric disorders (i.e. 
pleiotropy) has now been unequivocably demonstrated from genome-wide association studies 
(GWAS), as quantified by estimates of genetic correlation (rg) 
1, 2
. The rg estimates are 
highest between schizophrenia and bipolar disorder (0.67, standard error (s.e.) = 0.03) but are 
> 0.15 for any combination of the five common disorders of schizophrenia (SCZ), bipolar 
disorder (BIP), ADHD, Major Depression (MD) and autism spectrum disorders (AUT) 
2, 3
. 
Cross-diagnosis analyses can leverage power to identify genetic risk loci shared across 
classical diagnostic boundaries 
4
 and can increase power for risk prediction of disorders in 
independent samples 
5, 6
. The shared genetic basis for psychiatric disorders contributes to an 
evidence base supporting a trans-diagnostic approach in clinical practice 
7
. Nonetheless, 
traditional diagnostic classes reflect real symptom differences at patient presentation even 
though it can be difficult to classify some individuals given a high-degree of concurrent and 
longitudinal comordibity.  Since rg estimates are higher between data sets of the same 
disorder than between data sets of different disorders 
4, 8
 it implies some real biological basis 
to the classical diagnostic classes. Hence, a key question of importance in psychiatry is 
identification of genetic factors that are disorder specific rather than those shared across 
classical diagnostic groupings. Identifying such variants could aid in understanding the 
biological pathways that underlie the constellation of symptoms seen in each disorder.  
One method for identifying disorder-specific variants is to conduct a case-case 
GWAS with cases of one disorder compared to cases of another. The SCZ/BIP working 
group of the Psychiatric Genomics Consortium (PGC) conducted an association analysis 
comparing in logistic regression SCZ (N=23,585) vs BIP (N=15,270) cases to identify 
variants specific to each disorder. The cases were matched on ancestry and genotyping 
platform, hence the sample sizes were smaller than those available for the disorder specific 
GWAS which limits the statistical power. Conducting such analysis requires access to the 
raw genotypes which is not always feasible for all cohorts due to privacy laws. Methods that 
use summary statistics can utilise larger sample sizes without the need to provide access to 
raw daa to researchers. In addition, case-case GWAS can identify differences between pairs 
of disorders
9
, but does not generalize to the multivariate space to identify SNPs primarily 
associated one disorder.  
We conditioned the effect of SNPs estimated for one disorder on those of other 
disorders using multi-trait, conditional and joint analysis (mtCOJO)
10
, a summary-statistics 
based method that accounts for overlap in samples contributing to the disorder specific 
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GWAS. We report results from conditional analyses of 5 psychiatric disorders: SCZ, BIP, 
MD, ADHD and AUT using association summary statistics from meta-analyses conducted by 
the Psychiatric Genomics Consortium (PGC) including data from 23andMe. Each disorder is 
conditioned on the other four disorders in one model.  
 
Methods 
We applied the mtCOJO method as described in Zhu et al. 
10
. This method approximates a 
conditional analysis where the effect of a SNP on a disease is conditioned upon the covariates 
of the disease, but only requires summary statistics as input. As an example, if we are 
interested in estimating the effect of a SNP (z) on risk to schizophrenia (y) accounting for the 
effect of a covarying factor such as bipolar (x), we condition upon the effect of bipolar on 
schizophrenia 	 , as estimated using Generalised Summary-based Mendelian 
Randomisation (GSMR). This can be extended to condition upon multiple covarying diseases 
so that the effect of the SNP on risk on the disorder of interest is estimated conditional upon 
the covariates on the disorder (see Supplementary Material for detailed description of the 
method).  
 
To identify independent genome-wide significant SNPs for use as genetic instruments in 
mtCOJO analysis, each dataset was clumped to select independent genome-wide significant 
(GWS) SNPs (p < 5 x 10
-8
) using 7,762 unrelated individuals from the Atherosclerosis Risk 
In Community (ARIC) dataset
11
, imputed to 1000Genomes Phase III as an LD reference 
sample. GWS SNPs more than 1MB apart or with an r
2 
value < 0.05 were considered to be 
independent. GSMR accounts for any remaining LD between instruments. GSMR analysis 
with filtering to remove SNPs with outlier pleiotropic effects (compared to other GWS SNPs) 
using the HEIDI test 
12
 was performed with each disorder included both as an exposure and 
an outcome in combination with the other disorders. Owing to having fewer than 10 
independent GWS SNPs, independent SNPs significant at p < 10
-7
 were used for GSMR 
analysis with autism as the exposure variable. In order to compare the estimated effects of 
one disorder on another from MR, we derived a conversion of the estimated effects from 
GSMR to the liability scale (see Supplementary Material, Supplementary Figure 1). 
 
We performed mtCOJO analysis (implemented in GCTA
13
  
(http://cnsgenomics.com/software/gcta/#mtCOJO) of 5 genetically correlated psychiatric 
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disorders using the results from large genome-wide association studies from the Psychiatric 
GWAS consortium (Table 1), running the analysis in turn with each disorder as the outcome 
with the other disorders as covariates. A total of 5,275,400 SNPs with matching alleles that 
were in common across the 5 disorders were used for further analysis. Indels were excluded 
from the analysis.  
 
For each disorder, SNP effects conditional upon the other disorders were calculated. Results 
were uploaded to FUMA for annotation 
14
. Ranking SNPs according to the difference 
between the marginal and conditional effect sizes for each disorder is not necessarily 
meaningful because, for example, a SNP that has a low estimated marginal effect, so no 
effect on the outcome trait, will have a large conditional effect if the SNP has a large effect 
on the covariate traits. For the purposes of identifying which SNPs show evidence of 
disorder-specificity, we focus on presenting results for SNPs that were GWS with the 
outcome disorder in the original GWAS. We further estimated whether the difference 
between the conditional and raw effect size of each SNP was significant (Supplementary 
Material).  
 
MAGMA gene-set analysis 
MAGMA gene-set analysis
15
 as implemented in FUMA was used to investigate which sets of 






 was used to estimate the genetic correlation between the conditional 
and unadjusted GWAS results. 
 
Summary Mendelian Randomisation  
To investigate the potential functional relevance of SNPs with disorder-specific effects, we 
applied the SMR approach 
12
, integrating eQTL (SNP-gene expression association) and 
mQTL (SNP_DNA methylation association) to the results from the conditional analyses. 
eQTL data from brain tissue were derived from a meta-analysis of the GTEx study, the 
Common Mind Consortium (CMC) and the Religious Orders Study and Memory and Aging 
Project (ROSMAP). The details of the meta-analysis have been described elsewhere
17
. Using 
meta-analysis results across brain tissues and studies is justified owing to the high correlation 
 6
in effect sizes between tissues
17
. Only genes with a cis-eQTL with peQTL < 5 x 10
-8
 were 
included in the analysis. Experiment-wide significance accounting for testing multiple SNPs 
across multiple traits was set at pSMR = 1.9 x 10
-06
 and the threshold for no evidence of 
heterogeneity due to pleiotropy at pHEIDI > 0.01. Individual-level genotypes from the ARIC 
data (n = 7,762 unrelated individuals) 
11
 were used to estimate LD for the HEIDI test. 
 To test for the effects of disorder-specific variants on DNA methylation, we used 
SMR to integrating trait association data with meta-analysed brain mQTL data set from Jaffe 
et al. (n = 526) ROSMAP (n = 486) and fetal brain mQTL data from Hannon et al 
18
. Only 
probes with at least one cis-mQTL with p < 5 x 10
-8
 were included in the SMR analysis. 
Probes that passed the significance threshold of 1.56 x 10
-7
 and did not show evidence of 
heterogeneity as indicated by the HEIDI test were considered to be significant. 
 
Cell-type specificity for disorders 
To gain insight into the cell types that are important for each disorder, we evaluated whether 
genes associated with specific brain cell-types are enriched for association with each of the 
disorders. Using data from single-cell sequencing experiments in mice, the cell-type 
specificity of each gene was calculated by comparing the expression of a gene in a given cell-
type to that across all cell types 
19
. MAGMA was used to calculate gene-based association 
statistics and to evaluate whether genes with high specificity in a given cell-type are enriched 
for association with a disorder. The enrichment analysis was performed for both unadjusted 
and conditional GWAS for all 5 disorders. To investigate whether there was a significant 
change in the cell-type enrichment after conditioning, MAGMA analysis was performed 
using the enrichment Z-scores from the unadjusted GWAS as covariates in the analysis and a 
conditional enrichment for all level 1 cell types analysed in Skene et al. 
19
 was estimated. 
 
Code Availability 




After merging GWAS summary statistics for the five psychiatric disorders 5,275,400 
autosomal SNPs remained (Table 1). The number of independent genome-wide significant 
SNPs annotated by FUMA 
14
 is much greater for SCZ (M =130) compared to the other 
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disorders (M =16, 40, 11, 2 for BIP, MD, ADHD, AUT respectively) reflecting mostly 
sample size, but also genetic architecture, and population risk. Linkage disequilibrium score 
regression (LDSC) estimates of SNP-based heritability on the liability scale and genetic 
correlations were all significantly different from zero (Table 2). Genetic correlations were 
highest between SCZ and BIP (rg = 0.67 (s.e. = 0.03)) and lowest between BIP and ADHD (rg 
= 0.15 (s.e. = 0.04)). The LD-score regression intercept was significantly greater than zero 
for the majority of pairs of disorders reflecting sample overlap in the GWAS studies. The 
intercept was highest between ADHD and AUT due to substantial overlap in controls. See 
Supplementary Material for discussion of interpretation of results in the context of sample 
overlap.   
 
The GSMR analyses highlights some asymmetries in the estimates of the causal effects of 
one disorder on another (Table 3). In particular, the estimated liability	   when considering 
MD as an exposure for each trait is higher than the estimates in the reverse direction. One 
explanation is that since MD is so common and is frequently comorbid with other disorders 
that MD samples include those diagnosed and undiagnosed with other disorders. However, if 
model assumptions are violated it may have greater impact when there is a large difference in 
lifetime risk between the pairs of disorder. However, countering this, we find a higher  
from AUT to ADHD than from ADHD to AUT, but the standard errors on estimates are 
much higher for these disorders. Interpretation of these  estimates depends on the nature 
of the shared genetic contributions to psychiatric disorders that may reflect a complex mix of 
types of pleiotropy, where some sets shared of variants may have more correlated effect sizes 
than other sets of shared variants.  
 
Changes in Genetic Correlation  
The impact of the conditioning is demonstrated by the changes in the estimates of  
comparing original and conditional GWAS results. The  between SCZ conditional on the 
other disorders (denoted SCZcond) and SCZ remained high at 0.93, while between SCZcond and 
BIP it was much reduced (from 0.67 prior to conditioning to 0.36, after conditioning). It is 
noted that bzy is eliminated in the conditional analysis only if the SNP effect is mediated by 
trait x. Therefore, there is remaining genetic correlation because of pleiotropic SNP effects. A 
similar pattern of changes in genetic correlation with other traits was seen for the analyses 
with the other disorders as the outcome variable (Supplementary Table 1).  
 8
   
mtCOJO genome-wide significant SNP results 
As expected because of pleiotropy between disorders, conditional analysis leads to a 
reduction in the mean test statistic across all SNPs in the genome and hence the number of 
independent SNPs reaching the significance threshold (5x10
-8
) is reduced (Table 1). For each 
disorder, we present results for all independent SNPs significant in the unadjusted analysis or 
the conditional analysis (Supplementary Table 2). GWS SNPs that are more significantly 
associated in the conditional analysis than the unadjusted analysis are shown in Table 4. A 
larger conditional effect size suggests that these variants are disorder-specific or have 
heterogeneous effects across disorders.  
Given that SCZ is the disorder with the largest number of significant SNPs and for 
which the power to detect changes in effects is largest, we focus mostly on the results from 
the SCZ conditional analysis. Of the 130 SNPs from the unadjusted SCZ GWAS, five were 
more significant after adjusting for the other disorders (all of which had opposite direction of 
effects for BIP – Supplementary Table 2) and a further eight had a larger estimated effect 
size after conditioning. Forest plots for the four most significant SCZ SNPs from the 
conditional analysis (two of which were associated p<5x10
-8
 in the unadjusted analysis) are 
shown in Figure 1.  
For all disorders except for AUT, a number of SNPs surpass the significance 
threshold that were not significant in the original GWAS. For schizophrenia, ten SNPs that 
were significant in the conditional analysis and not in the original GWAS (Table 4). All 10 
SNPs have opposite effects for BIP, so that the allele that predisposes to SCZ is in the 
protective direction for BIP. Although these opposite effects could be due to ascertainment, 
among them are variants in or near genes with annotated biological functions that are 
potentially relevant for SCZ. For instance a  SNP that was significant in the conditional 
analysis (rs2973038 – padj = 1.28 x 10
-08
; pscz = 1.72 x 10
-06
 ) is located in the Glial Cell 
Derived Neurotrophic Factor (GDNF), a gene that encodes a protein that enhances the 
survival of midbrain dopaminergic neurons 
20
, and is expressed during development 
21
.  
All SNPs that were associated with BIP at p< 5x10
-8
 in the original GWAS were less 
significant in the conditional analysis, showing evidence that they have some pleiotropic 
effect across disorders. Notably, this includes genes involved in calcium signalling, 
dopaminergic signalling and synaptic plasticity, indicating these processes may be important 
across psychiatric disorders. Three SNPs that were not significant in the BIP GWAS were 
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significant in the conditional analysis (Table 4, Supplementary Table 2, Supplementary 
Figure 2).  
For each of the remaining disorders (MD, ADHD and AUT), we found that a small 
proportion of the existing significant SNPs had larger conditional effect sizes and one MD 
SNP and two ADHD SNPs that were not significant in the original GWAS became 
significant after conditioning (Table 4, Supplementary Table 2). However the difference in 
effect size after conditioning is not statistically significant for these SNPs, due to low 
statistical power (Supplementary Table 2). Forest plots for significant SNPs that had 
increased conditional effect sizes are shown in Supplementary Figures 3-5 
 
SMR analysis  
 Changes in the expression of 9 genes were significantly associated with the 5 
disorders (0 for BIP, 5 for SCZ, 3 for MD and 1 for ADHD, 0 for AUT) after conditioning 
and removal of genes in the MHC (Supplementary Tables 3-4), and a total of 72 DNA 
methylation sites (2 for BIP, 18 for SCZ, 37 for MD, 8 for ADHD, and 6 for AUT) were 
significantly associated with the 5 conditional traits (Supplementary Table 3-4).  
Significant SMR results for gene expression where the associated SNP is more 
significant in the conditional analysis are presented in Supplementary Table 3. Three out of 
5 significant SMR associations for SCZ were with SNPs where the conditional significance 
was greater than in the unadjusted analysis. One SNP - rs3759384 – is associated with 
decreased expression of VPS29 in the brain and significantly increased risk for SCZ in the 
unadjusted analysis and has a larger conditional effect size (Supplementary Figure 6), 
indicating that VPS29 may be linked to the development of SCZ and not other disorders. The 
VPS29 protein is a component of the retromer complex which prevents the degradation of 
certain proteins including signalling receptors, ion channels and small molecule transporters. 
The complex is essential for maintenance of neurons and has been implicated in the etiology 
of a number of neurodegenerative disorders 
22
.  
One of the three associations for MD was with a SNP (rs7732179) with greater 
significance in the conditional analysis. The same variant shows evidence of association with 
SCZ but with opposite directions of effect (bSCZ = -0.045; pSCZ = 1.7 x 10
-6
 and bBIP = -0.029; 
pBIP = 0.027). The A allele confers risk to MDD but is protective for SCZ and BIP 
(Supplementary Figure 7). The SNP is associated with expression of PCDHA7 in the brain. 
This gene encodes a member of the protocadherin family of genes located together on 
chromosome 5. A significant association was also found in this region in the DNA 
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methylation analysis of MD. Little is known about the exact function of these genes, however 
they are concentrated at the synaptic junction suggesting a key role in neuronal signalling 
23
.  
Out of 72 significant DNA methylation sites, 34 were associated with SNPs with 
higher significance in the conditional analyses (1 for BIP, 3 for SCZ, 21 for MD, 4 for 
ADHD and 5 for AUT) (Supplementary Table 3). It is noteworthy that one variant 
(rs2064853) was significantly associated with both SCZ and MD and DNA methylation near 
the CSE1L gene, but with opposite alleles increasing risk to each disorder (Supplementary 
Figure 8).  
 We investigated whether genes identified in the gene expression SMR or that are the 
closest gene to a significant methylation site are the primary target for FDA-approved drugs. 
We identified two genes that are targeted by medications. The serotonin receptor gene 
HTR1D which was identified in the DNA methylation analysis for MD is the primary target 
of the migraine drug naratriptan. Individuals with migraine are at 2-4 fold higher risk of 
developing depression and these results may suggest that triptans, used to treat migraines, 
could also be effective for MD.  
The second drug target identified is with MPL and ADHD. This gene is targeted by 
romiplostim, an orphan drug developed for treatment of chronic idiopathic thrombocytopenic 
purpura. 
 
MAGMA gene-set analyses 
We conducted MAGMA gene-set analysis in FUMA to identify pathways and gene-sets that 
are enriched for association with the disorders after conditional analyses and to identify 
which sets become more or less significant after conditioning. Results for each disorder are 
presented in Supplementary Table 5. After conservative Bonferroni correction for the 
number of gene-sets tested for each disorder, three gene sets were significant -  two for SCZ 
conditional analysis and one for AUT. For SCZ, the two significant sets were 
go:establishment of localization in the cell and GO:Dendrite, of which establishment of 
localization had a more significant p-value in the conditional analysis (Supplementary 
Table 5). For AUT, the gene-set GO:Dendrite_morphogenesis was significant after multiple 
testing and had a more significant p-value in the conditional analysis, potentially implicating 
genes expressed in dendrites in autism-specific pathology.   
 
Cell-type specificity for disorders  
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The results from the cell-type enrichment analyses of raw and conditional analyses are shown 
in Figure 2. Consistent with previous results, the original SCZ results were enriched in 
medium spiny neurons (MSNs), pyramidal CA1 cells, pyramidal SS1 cells, interneurons and 
serotonergic neurons (Supplementary Table 6). All of these cell types also show some 
evidence of association with BIP and to a lesser extent MD, consistent with the genetic 
correlation between disorders and hence show reduced enrichment in the SCZ conditional 
analysis. All enriched cell-types for SCZ remained significant after conditioning except for 
serotonergic neurons, indicating that genes specific to this cell-type may increase risk to all 
five disorders. Enrichment in interneurons was found for SCZ, BIP and MDD indicating their 
potential importance across all 3 disorders. After conditioning, this cell-type was still 
significantly enriched in SCZ and MDD, but not BIP. This may reflect that the sample size of 




Our goal was to identify genetic variants that show disorder specific association by 
conducting a summary statistics based GWAS analysis for each of five psychiatric disorders 
conditioning on GWAS results from the other disorders. As expected, given the high degree 
of pleiotropy across disorders, compared to original GWAS results the number of SNPs 
associated at the threshold of genome-wide significance is very much reduced for each 
conditional GWAS. We utilise mtCOJO as a method that uses summary statistics to quickly 
screen for SNP associations. Functional annotation can help prioritise the associations of 
most interest. It will be important to understand why a variant increases risk only to that 
disorder and not to others.  
By integrating conditional GWAS results with SNP-gene expression and SNP-
methylation results, we identify decreased expression of VPS29 as a potential biological 
mechanism underlying schizophrenia. The variant that increases risk to SCZ and is associated 
with decreased expression of VPS29 in brain tissue shows no evidence for association with 
other psychiatric disorders. The retromer complex, of which is VPS29 is a subunit, is highly 
conserved across eukaryotes. The complex plays a role in the recycling, delivery and 
degradation of proteins in the cell and is crucial in the maintenance of cell homeostasis
24
. 
Rare exonic mutations in members of the complex have been associated with Parkinson’s 
Disease and post-mortem studies have revealed decreased expression of all members of the 
complex in the brains of patients with Parkinson’s and Alzheimer’s disease. The expression 
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of all three members of the complex is linked such that decreasing expression of one leads to 
decreased expression of all of them. Knocking down VPS35 using siRNA leads to elevated 
generation of amyloid-beta and reduced synaptic transmission
25, 26
. There is therefore 
considerable interest in identifying pharmacological agents that prevent the degradation of 
the retromer complex as a therapeutic mechanism for neurodegenerative disease. Small 
molecule screens have identified potential therapeutic agents that have shown promise in 
vitro
27
. Our results provide that such compounds may of interest in targeting biological 
mechnisms specific to schizophrenia.    
Furthermore, SNPs associated with decreased expression of PCDH7 and decreased 
methylation near other members of the protocadherin gene family on chromosome 5 may 
increase risk of MD, but be protective for SCZ and BIP. The protocadherins are a large 
family of genes involved in cell-cell adhesion that are primarily expressed in the nervous 
system. They play a major role in the development of the nervous system and in regulating 
dendritic branching. The PCDHA7 gene is part of a complex cluster of protocadherin alpha 
genes in the same genomic locus. The expression of the different isoforms at the locus is 
controlled by upstream CpG sites. Owing to their functional role in nervous system 
development and their location in linkage peaks, the PCDHA genes have been investigated as 
candidate genes for bipolar and schizophrenia
28
. Moreover, an epigenetic study of concordant 
and discordant MZ twins for depression showed that affected twins had increased variation in 
methylation in the PCDHA region, highlighting instability in this region as a potential 
mechanism underlying depression
29
. Further studies of the role of the PCDHA gene cluster in 
psychopathology are warranted.   
Methylation in the promoter of the CSE1L gene, whose encoded protein influences 
cellular proliferation and has been linked to progression of a number of cancers, shows 
evidence of increasing risk to SCZ but being protective for MD.  
Consistent with the large degree of pleiotropy between disorders, we found that most 
of the significant biological pathways for each disorder had reduced significance after 
conditioning. Pathway analysis of conditional results identified a potential role for genes 
expressed in dendrites in both autism and schizophrenia. Likewise, for the cell-type 
enrichment analysis, there was a reduction in the enrichment for most cell types in each 
disorder after conditioning. For SCZ, the previously identified enrichments in pyramidal SS1 
and CA1 cells as well as medium spiny neurons remained significant after conditioning, 
despite also showing evidence for enrichment in BIP. The largest change in enrichment was 
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for serotonergic neurons, indicating that genes highly expressed there are important across all 
psychiatric disorders. 
We provide an analysis framework for conditional cross-disorder analyses using 
summary statistics. Our study was motivated to improve on the SCZ case vs. BIP case 
analyses that utilised PGC cohorts for which both SCZ and BIP genotyped samples were 
available 
30
, but which necessarily excluded 28% of cases that could not be allocated into 
matched cohorts. They identified 5 SNPs associated at p<5x10
-8
. We conducted an analysis 
of SCZ conditional on BIP and performed a lookup of those SNPs in the unadjusted and 
adjusted results. All but one (rs200005157) of their associated SNPs were matched directly or 
to an LD proxy (Supplementary Table 7). All show increased statistical significance in the 
conditional analysis. We identified more disorder-specific SNPs (10 specific to SCZ) 
consistent with the larger sample sizes afforded from using summary statistics, highlighting 
that mtCOJO is an efficient method for screening for disorder-specific SNPs for two or more 




There are a number of limitations to our analyses that should be considered. Although 
methods that utilise summary statistics have several advantages, they also depend upon the 
summary statistics being generated accurately. In this instance, all studies have gone through 
the same quality control and analysis pipeline meaning that systematic differences between 
studies are unlikely. It is not clear how misdiagnosis of cases would impact upon the results.  
There are also substantial differences in sample size between the GWAS of different 
disorders, with SCZ and MD having a larger sample size than the other disorders, which may 
disproportionately influence the results. This is shown by most of the significant differences 
in effect sizes between the raw and conditional results being for SCZ. The disorders that have 
the most genome-wide significant SNPs will also have the most accurate estimates of their 
effects on the disorders. As sample sizes increase for some of the other disorders, the results 
for those disorders will become more accurate.  
 In order to reduce the burden of multiple testing in the SMR analysis, we only 
included SNPs that are associated at the genome-wide significant level with gene expression 
or methylation in cis. Relaxing the statistical threshold for inclusion may have identified 
more SNPs with effects on gene expression in brain with the trade-off of increasing the 




In conclusion, our results suggest that mtCOJO is an efficient method for identifying 
variants with disorder-specific effects and they represent a small fraction of variants 
identified for each disorder to date, reflecting the high degree of pleiotropy between 
disorders. Nonetheless, we identify several loci that have evidence of being disorder-specific. 
Further research in human studies should focus on whether the disorder-specific variants 
associate with specific symptoms in mixed clinical populations. 
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Figure 1 – Forest plots for the 4 most significant SNPs in SCZ mtCOJO analysis with larger 
conditional effect sizes 
 









































Table 1. Summary of datasets used and results from conditional GWAS analysis 
 





























SCZ 40,675 64,643 5,471,613 130 Pardinas et al 2018 
145
0.01 43 10 15
BIP 20,352 31,358 9,498,970 16 Stahl et al 2018 BioRxiv 19 0.01 4 3 0
MD 135,458 344,901 10,468,943 40 Wray et al 2018 
44
0.15 15 1 5
ADHD 19,099 34,194 6,755,648 11 Demontis et al BioRxiv
12
0.05 5 2 3
AUT 18,381 27,969 7,539,669 2 Grove et al BioRxiv 
3








Table 2. Estimated SNP-based heritability on the liability scale, genetic correlation and 
LD-score intercepts estimated from LD-score regression 
  SCZ BIP MDD ADHD AUT 
SCZ 0.23 (0.01) 0.21 (0.01) 0.03 (0.01) 0.02 (0.01) 0.008 (0.01) 
BIP 0.67 (0.02) 0.19 (0.01) 0.05 (0.007) 0.03 (0.006) 0.009 (0.008) 
MD 0.36 (0.02) 0.35 (0.02) 0.08 (0.004) 0.10 (0.008) 0.09 (0.008) 
ADHD 0.18 (0.03) 0.15 (0.04) 0.43 (0.03) 0.22 (0.01) 0.35 (0.008) 
AUT 0.23 (0.05) 0.15 (0.05) 0.43 (0.04) 0.36 (0.05) 0.12 (0.01) 
LD-score SNP-based heritability on the liability scale and standard error reported on 
diagonal 
 rg and standard error reported below the diagonal 
Bivariate ldsc intercept reported above the diagonal. Value significantly greater than zero 


































Table 3. GSMR estimates of causal effect of each psychiatric disorder on the others with 
 21
conversion to the log odds ratio and liability scales 
Exposure Outcome N SNPs bxy bxy_se bxy_liability OR bxy_pval 
SCZ BIP 111 0.417 0.019 0.417 3.06 5.0E-109 
SCZ MD 111 0.074 0.007 0.109 1.22 4.9E-26 
SCZ ADHD 111 0.054 0.019 0.066 1.16 5.2E-03 
SCZ AUT 111 0.144 0.019 0.144 1.47 2.9E-09 
BIP SCZ 16 0.498 0.039 0.498 3.82 1.6E-37 
BIP MD 16 0.091 0.016 0.134 1.28 2.0E-08 
BIP ADHD 16 0.028 0.043 0.034 1.08 5.2E-01 
BIP AUT 16 0.123 0.046 0.123 1.39 7.4E-03 
MD SCZ 40 0.414 0.059 0.281 2.13 2.7E-12 
MD BIP 40 0.600 0.068 0.408 2.97 1.1E-18 
MD ADHD 40 0.402 0.072 0.339 2.09 2.9E-08 
MD AUT 40 0.463 0.078 0.314 2.33 3.7E-11 
ADHD BIP 13 0.135 0.052 0.109 1.34 8.9E-03 
ADHD MD 13 0.086 0.019 0.102 1.21 9.1E-06 
ADHD SCZ 13 0.156 0.043 0.126 1.40 2.8E-04 
ADHD AUT 11 0.333 0.060 0.269 2.06 2.9E-08 
AUT SCZ 11 0.063 0.041 0.063 1.19 1.3E-01 
AUT BIP 11 0.053 0.057 0.053 1.15 2.9E-01 
AUT MD 11 0.011 0.021 0.016 1.03 5.9E-01 
AUT ADHD 11 0.413 0.062 0.512 3.03 3.60E-11 
* Estimates using autism as the exposure used instruments with p < 10E-06 due to lack of 
















Table 4. Results for SNPs that were genome-wide significant in the conditional analysis and have larger estimated conditional effect sizes than in 
the original GWAS 
 















SCZ rs3764002 12 108618630 C 0.083 0.012 0.054 0.011 1.94E-12 6.05E-07 WSCD2 
SCZ rs6095357 20 47523865 A -0.069 0.011 -0.048 0.010 1.17E-10 1.21E-06 ARFGEF2 
SCZ rs7790864 7 28478625 A -0.062 0.011 -0.044 0.010 6.33E-09 7.18E-06 CREB5 
SCZ rs1054972 19 1852582 A 0.076 0.013 0.053 0.012 6.42E-09 1.32E-05 KLF16 
SCZ rs2867673 7 71752652 T 0.060 0.010 0.049 0.010 9.44E-09 4.11E-07 CALN1 
SCZ rs6564668 16 79457393 C -0.060 0.010 -0.038 0.010 1.05E-08 7.94E-05 RP11-467I7.1 
SCZ 
rs1192276
5 3 95047279 G -0.060 0.010 -0.044 0.010 1.22E-08 4.36E-06 RPS18P6 
SCZ rs2973038 5 37833781 C 0.066 0.012 0.051 0.011 1.28E-08 1.72E-06 GDNF 
SCZ 
rs1090394
5 10 363275 C 0.057 0.010 0.040 0.010 3.13E-08 3.30E-05 DIP2C 
SCZ 
rs1028293
5 8 38703797 A 0.058 0.011 0.041 0.010 3.97E-08 3.17E-05 TACC1 
SCZ rs6701877 1 174015259 G -0.096 0.014 -0.073 0.013 1.47E-11 2.37E-08 RP11-160H22.3 
SCZ rs7372313 3 135872958 G -0.069 0.010 -0.062 0.010 4.26E-11 1.54E-10 MSL2 
SCZ rs1765142 11 30378559 C 0.065 0.011 0.058 0.010 1.54E-09 1.13E-08 ARL14EP 
SCZ 
rs5564699
3 7 105017864 G -0.062 0.010 -0.053 0.010 2.23E-09 3.83E-08 SRPK2 
SCZ 
rs1504377
60 14 59981768 A 0.131 0.024 0.121 0.022 3.71E-08 4.58E-08 CCDC175 
BIP 
rs1255451
2 9 23352293 T -0.083 0.014 -0.066 0.014 1.55E-09 1.28E-06 ELAVL2 
BIP rs6891181 5 80849101 T -0.081 0.014 -0.075 0.014 1.49E-08 1.27E-07 SSBP2 
BIP 
rs1226891




0 20 47731767 T -0.031 0.005 -0.023 0.005 3.31E-09 3.53E-06 STAU1 
MD rs27732 5 87992576 A 0.034 0.005 0.031 0.005 1.22E-11 1.87E-10 MEF2C 
MD rs1806153 11 31850105 T 0.037 0.006 0.036 0.006 8.78E-10 1.18E-09 RCN1 
MD rs1354115 9 2983774 A 0.029 0.005 0.028 0.005 1.72E-08 2.37E-08 CARM1P1 
MD rs301799 1 8489302 T -0.028 0.005 -0.026 0.005 2.49E-08 4.68E-08 RERE 
ADHD 
rs7864810
4 6 50683009 T 0.136 0.023 0.124 0.025 4.31E-09 3.60E-07 TFAP2D 
ADHD rs2244336 10 8831827 C 0.071 0.013 0.069 0.014 3.81E-08 3.67E-07 ENSG00000270234 
ADHD 
rs1241044
4 1 44188719 A 0.107 0.014 0.106 0.015 4.23E-15 3.85E-13 ST3GAL3 
ADHD 
rs1302383
2 2 215219808 A 0.133 0.020 0.117 0.021 1.23E-11 1.62E-08 SPAG16 
ADHD rs281320 15 47769424 T -0.080 0.013 -0.074 0.013 1.84E-10 3.14E-08 SEMA6D 
AUT 
rs1009910
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1. Discussion of mtCOJO method for conditional GWAS analysis 
 
Multi-trait, conditional and joint analysis (mtCOJO)  
We used the mtCOJO methodology
1
 to conduct a conditional GWAS analysis of psychiatric 
disorders. mtCOJO was developed to generate GWAS summary statistics results for a target 
trait conditional on a covariate trait, recognising that the covariate trait is frequently not 
recorded in the individuals measured for the target trait. The mtCOJO method allows 
conditioning on the exposure by borrowing information from independently collected data, 
with the data linked through their SNP associations. Briefly, for two traits (y and x) with 
association effects for SNP z (  and  respectively) the association effect estimates for 
trait y conditional on trait x is estimated as | = −  (see Zhu et al. 1 for 
details), where  is the effect of trait x on trait y, as estimated in generalised summary-
based Mendelian randomisation (GSMR) analyses. If exposure trait x is causal of the 
outcome trait y or the two traits are pleiotropically related, we expect the genetic correlation 
estimated from the conditional GWAS result for trait y and that for trait x to be reduced by a 
factor proportional to the estimated effect of x on y. In a special case that if traits x and y are 
genetically identical we expect this correlation to be zero. 
Classical MR analyses have the hypothesis of causality of an exposure trait on an 
outcome trait. Here, when the two disease traits are psychiatric disorders, we have no 
hypothesis of causality, but rather use GSMR to demonstrate significant bi-directional 
association of SNPs that are GWS in one disorder with those in another disorder and to 





mtCOJO allows the analysis conditioning on multiple covarying diseases, so that the 
effect of a SNP on risk on the disorder of interest conditional upon the covariates on the 
disorder, is given by | = −  where  is the SNP effect on the disease, 
 is a t-length vector with the i-th element  being the effect of  on the disease when 
all the covariates are fitted jointly, and  is a t-length vector of SNP effects on x. The 
method is robust to sample overlap between studies. 
 
If the genetic correlation between two disorders is not driven by causality but a large 
number of pleiotropic effects (generally in the same direction) because of shared genetic 
pathways, then the GSMR  reflects an average pleiotropic association between the two 
disorders. Nonetheless, conditioning on the average effect has meaning, and our conditional 
results can be used in pathway analyses to identify functionally relevant pathways that are 
associated with a disorder after accounting for effects of covarying disorders. 
While it is possible that differences in quality control analysis or calling/imputation of SNPs 
across studies could lead to heterogeneity in the results and thus significant effects in the 
conditional analysis, these datasets were generated using the same analysis pipeline 
developed by the Psychiatric GWAS Consortium, and hence the likelihood of such 
heterogeneity is reduced. 
 
Estimating the significance of the difference between raw and conditional 
estimates. 
From Zhu et al, we know that the difference between the raw and the conditional 
estimates is = − | = , where ,  and  are defined the same as 
above. Therefore, the variance of the difference can be written as var = var =
 with  being the (co)variance matrix of 
1
. The significance of the difference 
can be estimated using the test-statistic = /var .  
If there is a single covariate trait, =  and var = var =var .The significance of the difference can be tested as = = =
. Therefore, it suggests the significance of the difference depends on the p-value of 




covariate traits is very small (no association), we do not expect to see large changes between 
the raw and conditional estimates. 
 
Interpreting results in the context of sample overlap 
From Zhu et al, the joint effects of the covarying traits on the outcome trait are given by =  
where = { , } is a ×  matrix with ,  being the genetic correlation between 
covariates i and j,  is a ×  diagonal matrix with the i-th diagonal element ℎ  being 
the SNP-based heritability for the i-th covariate. We estimate ℎ  and ,  from 
GWAS summary data using the LDSC. The calculated genetic correlations are free of bias 
caused by sample overlap. It is possible that the marginal effects  could be biased 
upwards due to sample overlap. However, as we are estimating the joint effects across 4 
disorders, any bias would be diluted as the joint effects will be smaller than the marginal 
effects and the other marginal effects are largely free from bias due to sample overlap.   
 The sampling variance of the mtCOJO test statistic |  is approximately var = var + − cov ,  where = var , and cov ,  is a t-length vector with the i-th element cov ,  being the covariance between  and . We know from our previous study 7 that cov , = , var var  where  is the proportion of sample overlap between  and y and ,  is the phenotypic correlation between  and y. More generally, if there is a sample overlap between y and x, ,  can be approximated by the intercept of a bivariate LDSC analysis between   and  ref .  is the sampling variance-covariance of  with the ij-th element cov , =




. We have shown that any bias in estimating  is likely to be small. (owever, if there is covariance between  and one or more of the elements of  this could bias the conditional estimates. (owever, for positively correlated traits with sample overlap, as is the case for AD(D and autism in this analysis, the bias will be downwards, such that more loci may appear to be shared across disorders, rather than disorder-specific. The implications for the interpretation of these analyses are that if the GWAS studies were conducted in completely independent samples, we may have detected more disorder-specific loci for autism and AD(D. (owever, given the relatively small sample size of the AD(D and autism studies compared to the other disorders, it is probable that the number of extra loci identified would be small.   
  
2. Discussion of pathway analysis results 
Across the five disorders, there were 3 Gene Ontology terms that were more significant after 
conditioning. The GO Biological Process – Establishment of Localization of the Cell – was 
more significantly enriched in schizophrenia after conditioning. This is a broad process that 
includes 1,925 genes and so it is not obvious as to how it may relate to the pathological 
mechanism of schizophrenia. Among the sub-categories of this process are axonal dopamine 
secretion, neurotransmitter reuptake and secretion, and postsynaptic neurotransmitter receptor 
cycle, so it may be of relevance to the pathophysiology of SCZ. VPS29 which was identified 
in the SMR analysis is part of this GO category.   
 Two other GO terms were significant after conditioning and accounting for multiple 
testing. across all disorders. Both relate to dendrites. The GO category “dendrite” was 
associated with SCZ but was less significant after conditioning. A related GO biological 
process “dendrite morphogenesis” was more significantly associated with autism after 
conditioning (p_adj = 2.9 x 10
-6 
, p_unadj = 1.9 x 10
-04
). This change in significance does not 
appear to be driven by the variant near SOX7 that was more significant after conditioning 
(Table 4). Decreased branching of dendrites in hippocampal neurons has been found in 




3. Summary of estimates of bxy for all combinations of quantitative and binary traits 
When estimating  using GSMR in instances where the exposure trait and outcome trait are 
quantitative traits and the effect sizes have been standardised, the effect estimate is directly 




estimated on the logit scale and used in mtCOJO. The estimates on the logit scale can be 
difficult to interpret when disorders have a different prevalence and the proportion of cases 
and controls used in the GWAS is different from the population prevalence We derive 
transformations to make the b  estimates interpretable when the exposure trait is a disease.  
 
The key transformations of the b  on the logit scale to the logOR and liability scale are 
 = −  
 = −−  
 
where Kx is the lifetime risk of the exposure trait and Ky is the lifetime risk of the outcome 
trait and  is the height of the normal distribution at the truncation point on the liability 
scale corresponding to risk K.  can be interpreted as the log of the odds ratio of y 
per 1 SD increase in liability in x. The estimate on the liability scale can be interpreted as the 
increase in liability in to disorder y per 1 SD increase in liability to x. Note that when two 
disorders have the same assumed prevalence, as is the case with schizophrenia and bipolar, =   . See the derivation below.  
 
For two traits (y and x) with association effect sizes for SNP z (  and , respectively) the 
association effect size estimates for trait y conditional on trait x  ( | )   is estimated as | ≈ | =  −  , where = { , , ⋯ , } with =/ , and ~ ,  where 1 is an m×1 vector of ones and V is the variance-
covariance matrix of , and m is the number of genome-wide significant SNPs selected as 
independently associated with trait x.  is the effect of trait x on trait y, which can be 
calculated through GSMR analysis,  =  1.  
 
When trait x is a dichotomous trait we denote the population lifetime risk as Kx,  as height 
of the normal curve when truncated at Kx, and the proportion of cases in the samples used to 




z is on the logit scale , such that exp( ) is the odds ratio of the SNP for 
cases of disease x. From Lloyd-Jones et al
3
, the relationship between and  on 
the observed scale from a case-control sample with proportion of cases  ( [ ] )  is 
 [ ] ≈   −  
 From Lee et al. 2011 
4
 and Dempster and Lerner
5
 the relationship between  on the 
liability scale and ( ) and [ ]   is  = [ ] .   (ence = .  So when y is a quantitative trait and x binary, the  calculated from available summary statistics is = : . A more interpretable regression coefficient is  =  =  : . Similarly, if y is a dichotomous phenotype, the  calculated from available summary statistics is = : , a more interpretable regression coefficient is either as logit of y per phenotypic liability SD unit of x: : = :  , or as phenotypic liability SD unit of y per phenotypic liability SD unit of x, : = =
: .  So, for schizophrenia and bipolar disorder since we assume =   = . , then : = : .  The interpretation and scaling of  for any combination of binary and quantitative traits is summarised in Supplementary Table 9. 
 
Supplementary Table 9. a  Units of  given = /  b  Scale of estimation Trait y is quantitativeLinear regression GWAS : Allelic effect in phenotypic SD units of y 
Trait y is binary disease 
Logistic regression GWAS 
: Allelic effect in ln OR  of 
y 
Trait x is quantitative 
Linear regression GWAS 
: Allelic effect in phenotypic SD units of x 
Estimated as    in phenotypic SD units of y per phenotypic SD unit of x 
:     value is logit SD units for disease 
y per phenotypic SD of trait x 




: Allelic effect in ln OR  of x  := − :  
 in SD unit of y per logit SD 
unit of x 
: =:  
  in logit SD units for disease y per phenotypic liability SD unit of x    := −− :   
 in SD units of liability of y per SD unit of liability to x 
 
4. Simulations to confirm derivations 
In order to confirm the derivations summarised in Supplementary Table 10, we performed a 
series of simulations. We simulated 100 SNPs from a binomial distribution z ~ B(2, p) with p 
being the allele frequency of a SNP p ~ U(0.01,0.5). We simulated an exposure phenotype 
under a liability-threshold model in (n=500,000 individuals) xliab = bzx z+ e, bzx ~ N(0,1), ~ , , where = var − , with   was the variance in x explained by z. 
We set = . . x was then standardized with mean 0 and variance 1. Ten different sets of 
cases and controls were assigned to the underlying simulated liability according to various 
disease prevalences (K) from 0.01 to 0.1. The sample size of cases was =  and that 
of controls was = − , where P was sample prevalence, P~U(0.1, 0.5). 
The cases and controls were randomly sampled from the whole population. In the simulation, 
we estimated  from the whole population by linear regression and  from the 
ascertained sample by logistic regression.  was then transformed to the liability 
scale. The simulation was replicated 1,000 times. The comparison of estimated and 
transformed  is shown in Supplementary Figure 8.  
 
In the second set of simulations, a dichotomous exposure phenotype was simulated as above 
with 4 different prevalences (Kx = 0.01, 0.04, 0.07 and 0.1) A outcome phenotype y with 
200,000 individuals was simulated under the model = +  , where ~ , . = var −  with  being the variance 
in y explained by x, = . . y was then standardized. We generated an ascertained 
sample for y using the same method as above. The four prevalences were the same as for 




 and  were estimated in the ascertained samples by logistic regression. 
 was then transformed to . The simulation was performed 1,000 times. 





Supplementary Table 10 shows the results from the simulation.  
 estimated from the logit scale. True  is 0.223 which generated  
ranging from 0.156 to 0.304 depending of Kx, Ky combinations 
Disease 
prevalence 
Scale = .  = .  = . 7 = .  












































The simulations show that the transformation to the liability scale from the logit scale is a 
good approximation of the true estimate of . The estimate is slightly downward 















































Supplementary Figure 2a-c. Significant SNPs from bipolar conditional analysis. All SNPs 






















Supplementary Figure 3(a-e) Genome-wide significant SNPs from mtCOJO analysis of major 















Supplementary Figure 4(a-e) Genome-wide significant SNPs from mtCOJO analysis of 














Supplementary Figure 5. Genome-wide significant SNP from mtCOJO analysis of AUT with 





























Supplementary Figure 6. Forest plot for mtCOJO analysis of rs3759384 – an eQTL for 





























Supplementary Figure 7. Forest plot for mtCOJO analysis of rs2064853 
 – an eQTL for PCDHA7 in brain– that was significant in SMR analysis and has opposite 




























Supplementary Figure 8. Forest plot for mtCOJO analysis of rs2064853 
 – an mQTL for DNA methylation in the promotor of the CSE1L gene – that was significant 
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Supplementary Table 2. Comparison between conditional and raw results for five psychiatric dis
Variants that are genome-wide significant in the adjusted analysis and have larger conditional e
SNPs where b_diff < 0 are SNPs with larger conditional effect size than raw effect size.
Disorder SNP chr pos A1_scz b_scz_adj se_scz_adj
SCZ rs3764002 12 108618630 C 0.083 0.012
SCZ rs6095357 20 47523865 A -0.069 0.011
SCZ rs7790864 7 28478625 A -0.062 0.011
SCZ rs1054972 19 1852582 A 0.076 0.013
SCZ rs2867673 7 71752652 T 0.060 0.010
SCZ rs6564668 16 79457393 C -0.060 0.010
SCZ rs11922765 3 95047279 G -0.060 0.010
SCZ rs2973038 5 37833781 C 0.066 0.012
SCZ rs10903945 10 363275 C 0.057 0.010
SCZ rs10282935 8 38703797 A 0.058 0.011
SCZ rs6701877 1 174015259 G -0.096 0.014
SCZ rs7372313 3 135872958 G -0.069 0.010
SCZ rs1765142 11 30378559 C 0.065 0.011
SCZ rs55646993 7 105017864 G -0.062 0.010
SCZ rs150437760 14 59981768 A 0.131 0.024
SCZ rs13201681 6 28394680 C -0.196 0.019
SCZ rs2660304 1 98512127 G 0.106 0.013
SCZ rs4766428 12 110723245 C 0.081 0.011
SCZ rs6065094 20 37453194 A -0.074 0.011
SCZ rs12293670 11 124612932 A 0.072 0.011
SCZ rs11783093 8 27425349 C -0.094 0.015
SCZ rs4129585 8 143312933 A 0.066 0.010
SCZ rs2851447 12 123665113 G -0.074 0.012
SCZ rs7432375 3 136288405 G -0.066 0.011
SCZ rs13135092 4 103198082 A -0.125 0.020
SCZ rs34796896 3 180623255 G -0.078 0.013
SCZ rs6002655 22 42603814 C 0.063 0.011
SCZ rs7951870 11 46373311 T -0.082 0.014
SCZ rs11874716 18 52750688 T 0.061 0.010
SCZ rs16867576 5 88746331 A 0.094 0.016
SCZ rs4144797 2 233562197 T 0.063 0.011
SCZ rs12416331 10 104928914 T -0.106 0.018
SCZ rs7632834 3 17886678 T -0.060 0.010
SCZ rs4936215 11 133852684 A 0.075 0.013
SCZ rs12129573 1 73768366 C 0.061 0.011
SCZ rs9461856 6 33395199 G 0.059 0.010
SCZ rs10503253 8 4180844 C 0.071 0.013
SCZ rs62334820 4 176855221 C 0.073 0.013
SCZ rs1353545 3 60287845 G 0.061 0.011
SCZ rs7632921 3 71543758 G -0.058 0.011
SCZ rs2949006 2 200715388 T 0.071 0.013
SCZ rs7129727 11 57484660 G 0.061 0.011
SCZ rs9607782 22 41587556 T 0.067 0.012
SCZ rs17465671 16 63712719 C -0.058 0.011
SCZ rs301818 1 8503242 G 0.060 0.011
SCZ rs7596038 2 58383820 C -0.056 0.010
SCZ rs10148671 14 29469373 T -0.059 0.011
SCZ rs12705761 7 110976264 G -0.058 0.011
SCZ rs1451488 2 199990107 A -0.056 0.010
SCZ rs58950470 11 65383755 G 0.059 0.011
SCZ rs2053079 19 30987423 A -0.064 0.012
SCZ rs2007044 12 2344960 A -0.056 0.010
SCZ rs2917569 11 132568255 T 0.056 0.010
SCZ rs1899543 11 24406419 A -0.055 0.010
SCZ rs12668848 7 2020995 G -0.055 0.010
SCZ rs9403484 6 143651969 C 0.064 0.012
SCZ rs14403 1 243663893 C -0.065 0.013
SCZ rs36043959 8 111472014 G 0.065 0.013
SCZ rs1473594 8 60696526 T 0.053 0.010
SCZ rs6680011 1 95840866 A -0.073 0.014
SCZ rs1080500 3 53175017 G -0.056 0.011
SCZ rs7701440 5 60620980 T -0.051 0.010
SCZ rs3743078 15 78894759 C -0.060 0.012
SCZ rs12129719 1 66324512 G 0.052 0.011
SCZ rs12628643 22 40015493 C 0.053 0.011
SCZ rs2332700 14 72417326 C 0.057 0.012
SCZ rs7789569 7 104927586 T 0.052 0.011
SCZ rs760608 6 114719447 G -0.056 0.012
SCZ rs7216638 17 2156453 T -0.053 0.011
SCZ rs2905432 19 19484295 G -0.051 0.011
SCZ rs1319017 9 84736303 G 0.052 0.011
SCZ rs215411 4 23423603 T 0.052 0.011
SCZ rs7499750 16 13749265 A 0.057 0.012
SCZ rs7801375 7 131567263 A -0.067 0.014
SCZ rs10791097 11 130718630 T 0.048 0.010
SCZ rs36104021 12 103361112 C 0.078 0.017
SCZ rs12704290 7 86427626 G -0.075 0.016
SCZ rs1120004 12 23633432 T 0.055 0.012
SCZ rs7142769 14 104228841 C 0.051 0.011
SCZ rs7893279 10 18745105 T 0.077 0.017
SCZ rs10520163 4 170626552 T 0.047 0.010
SCZ rs12148337 15 70589272 T 0.047 0.010
SCZ rs281299 15 47686081 C 0.048 0.011
SCZ rs6434928 2 198304577 G -0.049 0.011
SCZ rs4650963 1 177309490 G 0.070 0.016
SCZ rs1191551 14 30000405 T 0.056 0.013
SCZ rs6035706 20 20821005 A -0.050 0.011
SCZ rs211829 7 110048893 T 0.047 0.011
SCZ rs4925114 17 17711270 A 0.049 0.011
SCZ rs2514218 11 113392994 C -0.049 0.011
SCZ rs2970610 1 44097530 T 0.048 0.011
SCZ rs11646127 16 29966277 G -0.047 0.011
SCZ rs6800435 3 10804551 C 0.070 0.016
SCZ rs324015 12 57490100 T -0.054 0.012
SCZ rs2910032 5 152540354 C -0.045 0.010
SCZ rs12898315 15 61854003 G 0.045 0.010
SCZ rs4240748 12 92246786 C -0.046 0.011
SCZ rs17514846 15 91416550 A -0.045 0.011
SCZ rs10985817 9 101071090 T -0.060 0.014
SCZ rs2161711 16 71359066 A 0.058 0.014
SCZ rs1339227 6 73155701 C -0.046 0.011
SCZ rs16902086 5 45285752 A -0.046 0.011
SCZ rs489939 3 161470592 G -0.045 0.011
SCZ rs7010876 8 89264751 T -0.048 0.012
SCZ rs10783624 12 39522907 C -0.046 0.011
SCZ rs3735025 7 137074844 T 0.044 0.011
SCZ rs35346733 3 2521322 G 0.055 0.013
SCZ rs704373 3 63867355 A 0.045 0.011
SCZ rs6694545 1 30437268 A 0.049 0.012
SCZ rs13121251 4 143829759 T 0.045 0.011
SCZ rs217287 6 84407466 C -0.042 0.010
SCZ rs1975802 16 68285847 A -0.053 0.014
SCZ rs783540 15 83254708 A -0.040 0.010
SCZ rs11685299 2 225391296 C -0.043 0.011
SCZ rs28374258 1 190949551 T 0.050 0.013
SCZ rs9881798 3 16846967 A -0.040 0.011
SCZ rs133047 22 41027819 T 0.066 0.017
SCZ rs12991836 2 145141541 A -0.041 0.011
SCZ rs56873913 19 50091199 T 0.048 0.013
SCZ rs2077586 2 73161551 A 0.045 0.012
SCZ rs12447860 16 58642638 T -0.039 0.011
SCZ rs11587347 1 239198959 C -0.066 0.018
SCZ rs2410572 8 18421474 G -0.038 0.010
SCZ rs10196799 2 185640728 A 0.038 0.010
SCZ rs1042992 8 26269191 C 0.049 0.014
SCZ rs55669358 8 34312412 T -0.065 0.018
SCZ rs9545047 13 79859456 A 0.037 0.011
SCZ rs10156310 8 38209129 A 0.045 0.013
SCZ rs56145559 2 73623439 C 0.044 0.013
SCZ rs634940 6 93077500 G 0.041 0.012
SCZ rs11993663 8 10032894 C 0.036 0.011
SCZ rs7225476 17 78561603 G 0.034 0.010
SCZ rs13169274 5 137855305 T -0.035 0.010
SCZ rs893949 11 134296384 C -0.030 0.011
SCZ rs12908161 15 85207825 A 0.033 0.012
SCZ rs11584091 1 150101169 C -0.038 0.014
SCZ rs75968099 3 36858583 C 0.029 0.011
SCZ rs35604463 14 99712032 G -0.028 0.011
SCZ rs7191183 16 9900057 T -0.029 0.011
SCZ rs112509803 7 24735004 G 0.030 0.016
Disorder SNP chr pos A1_bip b_bip_adj se_bip_adj
BIP rs12554512 9 23352293 T -0.083 0.014
BIP rs6891181 5 80849101 T -0.081 0.014
BIP rs12268910 10 111878510 T -0.097 0.018
BIP rs9834970 3 36856030 T -0.074 0.013
BIP rs73496688 11 79156748 A 0.103 0.019
BIP rs111444407 19 19358207 T 0.099 0.018
BIP rs11724116 4 162294038 T -0.099 0.019
BIP rs884301 17 53367464 T 0.072 0.014
BIP rs329319 5 133906609 A 0.073 0.014
BIP rs2314398 2 97413488 C 0.071 0.014
BIP rs10455979 6 166995260 C -0.064 0.014
BIP rs174592 11 61618608 A -0.064 0.014
BIP rs55648125 6 50816718 A -0.098 0.021
BIP rs138321 22 41209304 A 0.059 0.013
BIP rs2302417 3 52814256 A -0.058 0.014
BIP rs71395455 15 85153804 A 0.063 0.015
BIP rs13231398 7 110197412 C -0.091 0.022
BIP rs17150022 7 24771777 T -0.078 0.020
BIP rs10744560 12 2387099 T 0.038 0.014
Disorder SNP chr pos A1_mdd b_md_adj se_md_adj
MD rs11697370 20 47731767 T -0.031 0.005
MD rs27732 5 87992576 A 0.034 0.005
MD rs1806153 11 31850105 T 0.037 0.006
MD rs1354115 9 2983774 A 0.029 0.005
MD rs301799 1 8489302 T -0.028 0.005
MD rs12552 13 53625781 A 0.040 0.005
MD rs1432639 1 72813218 A 0.038 0.005
MD rs8025231 15 37648402 A -0.031 0.005
MD rs915057 14 64686207 A -0.030 0.005
MD rs11135349 5 164523472 A -0.028 0.005
MD rs12958048 18 53101598 A 0.030 0.005
MD rs4904738 14 42179732 T -0.028 0.005
MD rs12129573 1 73768366 A 0.029 0.005
MD rs12666117 7 109105611 A 0.027 0.005
MD rs159963 1 8504421 A -0.028 0.005
MD rs16854051 4 42123892 T -0.033 0.006
MD rs1363104 5 103917797 C 0.027 0.005
MD rs10149470 14 104017953 A -0.027 0.005
MD rs4261101 1 90796053 A -0.028 0.005
MD rs2389016 1 80799329 T 0.029 0.005
MD rs7430565 3 158107180 A -0.026 0.005
MD rs10959913 9 11544964 T 0.031 0.006
MD rs6905391 6 28262686 A -0.037 0.007
MD rs5758265 22 41617897 A 0.029 0.006
MD rs11643192 16 72214276 A 0.026 0.005
MD rs4074723 12 23947737 A -0.026 0.005
MD rs7198928 16 7666402 T 0.027 0.005
MD rs2005864 14 75377692 T 0.026 0.005
MD rs7029033 9 126682068 T 0.048 0.010
MD rs10950398 7 12264871 A 0.025 0.005
MD rs62099069 18 36883737 A -0.025 0.005
MD rs4869056 5 166992078 A -0.025 0.005
MD rs7856424 9 119733595 T -0.027 0.005
MD rs1226412 2 157111313 T 0.030 0.006
MD rs4143229 13 44327799 A -0.045 0.009
MD rs11682175 2 57987593 T -0.023 0.005
MD rs11663393 18 50614732 A 0.024 0.005
MD rs8063603 16 6310645 A -0.025 0.005
MD rs77135925 17 27495269 T -0.041 0.009
MD rs61867293 10 106563924 T -0.028 0.006
MD rs7200826 16 13066833 T 0.025 0.006
Disorder SNP chr pos A1_adhd b_adhd_adj se_adhd_adj
ADHD rs78648104 6 50683009 T 0.136 0.023
ADHD rs2244336 10 8831827 C 0.071 0.013
ADHD rs12410444 1 44188719 A 0.107 0.014
ADHD rs13023832 2 215219808 A 0.133 0.020
ADHD rs281320 15 47769424 T -0.080 0.013
ADHD rs74760947 8 34352610 A -0.168 0.030
ADHD rs4858241 3 20669071 T 0.071 0.013
ADHD rs1427829 12 89760744 A 0.066 0.013
ADHD rs10262192 7 114091753 A 0.063 0.012
ADHD rs212178 16 72578131 A -0.090 0.019
ADHD rs11591402 10 106747354 A -0.067 0.015
ADHD rs4916723 5 87854395 A -0.050 0.013
ADHD rs2391769 1 96978961 A -0.045 0.013
Disorder SNP chr pos A1_aut b_aut_adj se_aut_adj
AUT rs10099100 8 10576775 C 0.084 0.014
AUT rs910805 20 21248116 A 0.077 0.015
sorders
ffect sizes than raw effect sizes are highlighted in blue
p_scz_adj b_scz_unadj se_scz_unadj p_scz_unadj b_scz_diff se_diff p_diff
1.94E-12 0.054 0.011 6.05E-07 -0.029 0.007 8.68E-05
1.17E-10 -0.048 0.010 1.21E-06 -0.021 0.007 1.47E-03
6.33E-09 -0.044 0.010 7.18E-06 -0.018 0.007 7.04E-03
6.42E-09 0.053 0.012 1.32E-05 -0.024 0.008 3.93E-03
9.44E-09 0.049 0.010 4.11E-07 -0.011 0.006 8.49E-02
1.05E-08 -0.038 0.010 7.94E-05 -0.022 0.006 7.15E-04
1.22E-08 -0.044 0.010 4.36E-06 -0.015 0.006 1.82E-02
1.28E-08 0.051 0.011 1.72E-06 -0.015 0.007 3.96E-02
3.13E-08 0.040 0.010 3.30E-05 -0.017 0.006 5.64E-03
3.97E-08 0.041 0.010 3.17E-05 -0.017 0.006 7.55E-03
1.47E-11 -0.073 0.013 2.37E-08 -0.023 0.009 9.69E-03
4.26E-11 -0.062 0.010 1.54E-10 -0.007 0.006 2.80E-01
1.54E-09 0.058 0.010 1.13E-08 -0.008 0.007 2.27E-01
2.23E-09 -0.053 0.010 3.83E-08 -0.009 0.006 1.49E-01
3.71E-08 0.121 0.022 4.58E-08 -0.010 0.014 4.92E-01
5.98E-26 -0.235 0.017 1.32E-41 0.039 0.011 4.71E-04
1.56E-15 0.108 0.012 2.18E-18 0.003 0.008 7.46E-01
6.00E-14 0.076 0.010 2.68E-14 -0.005 0.007 4.67E-01
2.03E-11 -0.085 0.010 7.91E-17 0.011 0.007 9.75E-02
6.98E-11 0.081 0.010 1.70E-15 0.009 0.007 1.71E-01
1.30E-10 -0.093 0.014 7.64E-12 0.000 0.009 9.57E-01
1.62E-10 0.082 0.010 9.26E-18 0.016 0.006 1.26E-02
2.45E-10 -0.087 0.011 5.55E-16 0.013 0.007 6.11E-02
2.96E-10 -0.068 0.010 4.07E-12 0.001 0.006 8.26E-01
3.58E-10 -0.149 0.018 7.87E-16 0.024 0.012 5.20E-02
1.57E-09 -0.083 0.012 3.19E-12 0.006 0.008 4.71E-01
3.01E-09 0.075 0.010 2.15E-14 0.012 0.006 5.91E-02
3.16E-09 -0.093 0.013 2.99E-13 0.012 0.008 1.72E-01
3.52E-09 0.072 0.010 8.44E-14 0.010 0.006 1.09E-01
5.23E-09 0.101 0.015 1.65E-11 0.007 0.010 4.91E-01
5.87E-09 0.082 0.010 4.33E-16 0.019 0.007 4.76E-03
7.02E-09 -0.145 0.017 7.09E-18 0.040 0.011 3.59E-04
8.54E-09 -0.058 0.010 2.52E-09 -0.002 0.006 7.23E-01
8.72E-09 0.091 0.012 5.32E-14 0.016 0.008 3.69E-02
8.93E-09 0.076 0.010 8.94E-15 0.015 0.007 1.92E-02
9.21E-09 0.071 0.010 1.68E-13 0.011 0.006 7.57E-02
1.52E-08 0.066 0.012 9.60E-09 -0.005 0.008 5.35E-01
1.69E-08 0.081 0.012 9.60E-12 0.009 0.008 2.75E-01
2.10E-08 0.059 0.010 5.67E-09 -0.002 0.007 7.33E-01
4.11E-08 -0.057 0.010 9.52E-09 -0.001 0.006 8.17E-01
4.33E-08 0.100 0.012 3.69E-17 0.029 0.008 2.46E-04
4.50E-08 0.063 0.010 1.47E-09 0.001 0.007 8.71E-01
4.61E-08 0.081 0.011 5.54E-13 0.015 0.008 5.20E-02
5.08E-08 -0.058 0.010 4.14E-09 0.000 0.006 9.93E-01
5.10E-08 0.060 0.010 3.79E-09 0.000 0.007 9.82E-01
5.52E-08 -0.067 0.010 2.37E-12 0.011 0.006 8.73E-02
6.76E-08 -0.063 0.010 5.46E-10 0.004 0.007 5.41E-01
6.96E-08 -0.066 0.010 5.11E-11 0.007 0.007 2.61E-01
7.22E-08 -0.067 0.010 4.75E-12 0.011 0.006 9.62E-02
8.72E-08 0.057 0.010 2.07E-08 -0.002 0.007 8.10E-01
9.65E-08 -0.071 0.011 1.82E-10 0.007 0.007 3.67E-01
9.74E-08 -0.089 0.010 5.63E-20 0.033 0.006 3.98E-07
9.89E-08 0.061 0.010 3.11E-10 0.005 0.006 4.29E-01
1.05E-07 -0.058 0.009 1.23E-09 0.003 0.006 6.28E-01
1.13E-07 -0.085 0.010 1.11E-18 0.030 0.006 3.19E-06
1.68E-07 0.064 0.011 1.41E-08 0.000 0.007 9.77E-01
1.80E-07 -0.074 0.012 1.71E-10 0.009 0.008 2.58E-01
2.89E-07 0.080 0.012 4.07E-12 0.016 0.008 4.37E-02
3.25E-07 0.064 0.010 3.33E-11 0.011 0.006 9.63E-02
3.98E-07 -0.074 0.013 2.83E-08 0.001 0.009 9.50E-01
5.40E-07 -0.072 0.010 2.71E-12 0.016 0.007 2.32E-02
7.61E-07 -0.072 0.010 3.72E-14 0.021 0.006 6.42E-04
7.82E-07 -0.078 0.011 3.11E-12 0.018 0.007 1.42E-02
9.83E-07 0.054 0.010 3.35E-08 0.002 0.007 7.27E-01
1.03E-06 0.070 0.010 3.03E-12 0.017 0.007 9.52E-03
1.37E-06 0.070 0.011 1.52E-10 0.013 0.007 7.99E-02
1.93E-06 0.065 0.010 7.00E-11 0.014 0.007 3.90E-02
1.94E-06 -0.061 0.011 1.90E-08 0.005 0.007 4.85E-01
1.98E-06 -0.065 0.010 4.59E-10 0.011 0.007 9.52E-02
2.16E-06 -0.069 0.010 6.62E-12 0.017 0.007 8.89E-03
2.36E-06 0.066 0.010 7.82E-11 0.014 0.007 3.55E-02
2.70E-06 0.058 0.010 1.40E-08 0.006 0.007 3.51E-01
2.89E-06 0.071 0.011 4.24E-10 0.014 0.007 6.73E-02
3.04E-06 -0.077 0.013 6.27E-09 0.010 0.009 2.28E-01
3.12E-06 0.063 0.010 3.29E-11 0.015 0.006 1.72E-02
3.36E-06 0.090 0.016 7.31E-09 0.012 0.010 2.36E-01
3.40E-06 -0.114 0.015 3.57E-14 0.039 0.010 8.75E-05
3.41E-06 0.062 0.011 1.42E-08 0.007 0.007 3.19E-01
3.80E-06 0.077 0.010 4.51E-14 0.026 0.007 1.00E-04
4.09E-06 0.111 0.015 4.80E-13 0.035 0.010 7.19E-04
4.87E-06 0.053 0.010 2.81E-08 0.006 0.006 3.55E-01
5.79E-06 0.054 0.010 1.16E-08 0.008 0.006 2.30E-01
5.87E-06 0.055 0.010 2.19E-08 0.007 0.007 2.98E-01
6.34E-06 -0.073 0.010 3.62E-13 0.024 0.007 4.19E-04
7.54E-06 0.082 0.014 1.16E-08 0.012 0.010 1.98E-01
8.02E-06 0.073 0.012 4.12E-10 0.017 0.008 2.97E-02
8.08E-06 -0.060 0.010 7.24E-09 0.010 0.007 1.66E-01
8.44E-06 0.059 0.010 2.29E-09 0.012 0.007 7.60E-02
8.59E-06 0.057 0.010 2.64E-08 0.008 0.007 2.40E-01
8.87E-06 -0.073 0.010 2.42E-12 0.023 0.007 4.93E-04
9.27E-06 0.068 0.010 1.39E-11 0.020 0.007 3.01E-03
1.04E-05 -0.071 0.010 5.52E-13 0.024 0.007 2.22E-04
1.05E-05 0.082 0.015 2.00E-08 0.012 0.010 2.27E-01
1.08E-05 -0.072 0.011 1.42E-10 0.018 0.008 1.72E-02
1.18E-05 -0.063 0.010 3.72E-11 0.018 0.006 3.93E-03
1.40E-05 0.057 0.010 2.51E-09 0.012 0.006 5.55E-02
1.96E-05 -0.056 0.010 2.15E-08 0.010 0.007 1.38E-01
2.03E-05 -0.069 0.010 2.55E-12 0.023 0.007 3.97E-04
2.09E-05 -0.080 0.013 1.02E-09 0.020 0.009 2.25E-02
2.17E-05 0.070 0.013 4.22E-08 0.012 0.008 1.57E-01
2.23E-05 -0.063 0.010 3.76E-10 0.017 0.007 1.15E-02
2.56E-05 -0.066 0.010 5.55E-11 0.020 0.007 2.93E-03
2.80E-05 -0.057 0.010 1.24E-08 0.012 0.007 7.16E-02
3.11E-05 -0.062 0.011 6.51E-09 0.014 0.007 5.16E-02
3.56E-05 -0.060 0.010 5.44E-09 0.014 0.007 4.00E-02
3.84E-05 0.065 0.010 7.02E-11 0.020 0.007 1.95E-03
4.27E-05 0.087 0.012 2.42E-12 0.032 0.008 9.34E-05
4.61E-05 0.065 0.010 1.39E-10 0.020 0.007 3.19E-03
5.23E-05 0.077 0.011 6.20E-12 0.028 0.007 2.10E-04
6.08E-05 0.057 0.010 4.06E-08 0.012 0.007 7.80E-02
6.13E-05 -0.069 0.010 9.53E-13 0.027 0.006 2.30E-05
8.92E-05 -0.069 0.013 3.56E-08 0.016 0.008 5.41E-02
1.04E-04 -0.059 0.010 8.45E-10 0.019 0.006 3.73E-03
1.06E-04 -0.060 0.010 3.86E-09 0.017 0.007 1.03E-02
1.13E-04 0.073 0.012 6.35E-10 0.024 0.008 2.69E-03
1.31E-04 -0.054 0.010 2.81E-08 0.014 0.006 3.34E-02
1.39E-04 0.094 0.016 3.47E-09 0.028 0.011 9.28E-03
1.44E-04 -0.061 0.010 6.46E-10 0.020 0.007 3.14E-03
1.56E-04 0.070 0.012 2.58E-09 0.022 0.008 6.46E-03
1.61E-04 0.061 0.011 2.96E-08 0.016 0.007 2.53E-02
2.13E-04 -0.062 0.010 3.28E-10 0.023 0.006 3.56E-04
2.19E-04 -0.103 0.017 4.82E-10 0.037 0.011 7.69E-04
2.22E-04 -0.055 0.010 1.07E-08 0.016 0.006 9.08E-03
2.52E-04 0.056 0.010 4.51E-09 0.018 0.006 4.22E-03
2.75E-04 0.073 0.012 3.67E-09 0.024 0.008 4.21E-03
3.44E-04 -0.095 0.017 1.37E-08 0.030 0.011 5.71E-03
4.01E-04 0.056 0.010 1.15E-08 0.019 0.006 4.09E-03
4.10E-04 0.073 0.012 5.56E-10 0.028 0.008 4.01E-04
4.86E-04 0.072 0.012 1.01E-09 0.027 0.008 3.81E-04
6.73E-04 0.063 0.011 1.30E-08 0.023 0.007 1.91E-03
7.97E-04 0.055 0.010 3.40E-08 0.019 0.007 4.81E-03
8.45E-04 0.052 0.010 4.86E-08 0.018 0.006 5.32E-03
9.01E-04 -0.060 0.010 7.06E-10 0.025 0.006 8.66E-05
3.82E-03 -0.053 0.010 2.98E-08 0.023 0.007 5.00E-04
5.43E-03 0.067 0.011 9.41E-10 0.034 0.007 1.79E-06
7.39E-03 -0.081 0.013 8.63E-10 0.043 0.009 4.68E-07
8.31E-03 0.066 0.010 9.41E-11 0.037 0.007 2.26E-08
9.88E-03 -0.056 0.010 1.66E-08 0.029 0.006 1.03E-05
9.91E-03 -0.060 0.010 6.31E-09 0.031 0.007 6.25E-06
6.02E-02 0.084 0.015 2.31E-08 0.053 0.010 6.67E-08
p_bip_adj b_bip_unadj se_bip_unadjp_bip_unadj b_bip_diff se_bip_diff p_bip_diff
1.55E-09 -0.066 0.014 1.28E-06 -0.016 0.005 1.034E-03
1.49E-08 -0.075 0.014 1.27E-07 -0.005 0.005 3.045E-01
3.29E-08 -0.091 0.018 2.73E-07 -0.006 0.006 3.142E-01
2.52E-08 -0.101 0.013 5.53E-14 0.027 0.005 2.934E-08
5.28E-08 0.109 0.019 1.05E-08 0.006 0.007 4.209E-01
6.25E-08 0.117 0.018 2.40E-10 0.017 0.007 9.750E-03
1.37E-07 -0.104 0.019 3.27E-08 0.005 0.007 4.042E-01
1.60E-07 0.080 0.014 5.80E-09 0.008 0.005 9.837E-02
1.66E-07 0.079 0.014 1.54E-08 0.006 0.005 2.062E-01
7.83E-07 0.084 0.014 5.92E-09 0.013 0.005 1.015E-02
2.94E-06 -0.075 0.014 4.60E-08 0.011 0.005 2.115E-02
4.95E-06 -0.077 0.014 3.66E-08 0.013 0.005 8.251E-03
5.00E-06 -0.117 0.022 4.92E-08 0.019 0.008 1.241E-02
1.15E-05 0.079 0.014 4.69E-09 0.020 0.005 2.927E-05
1.66E-05 -0.079 0.014 4.93E-09 0.021 0.005 1.356E-05
1.75E-05 0.082 0.015 1.93E-08 0.020 0.005 2.065E-04
3.31E-05 -0.121 0.022 3.36E-08 0.030 0.008 1.223E-04
1.30E-04 -0.113 0.020 2.70E-08 0.035 0.007 1.715E-06
6.26E-03 0.083 0.014 2.92E-09 0.045 0.005 5.766E-19
p_md_adj b_md_unadj se_md_unadjp_md_unadj b_md_diff se_md_diff p_md_diff
3.31E-09 -0.023 0.005 3.53E-06 0.007 0.002 2.04E-05
1.22E-11 0.031 0.005 1.87E-10 0.003 0.002 5.96E-02
8.78E-10 0.036 0.006 1.18E-09 0.001 0.002 5.10E-01
1.72E-08 0.028 0.005 2.37E-08 0.001 0.002 5.53E-01
2.49E-08 -0.026 0.005 4.68E-08 0.001 0.002 4.70E-01
1.66E-15 0.043 0.005 6.07E-19 0.003 0.002 4.15E-02
9.37E-14 0.039 0.005 4.55E-15 0.001 0.002 7.61E-01
3.39E-10 -0.034 0.005 2.36E-12 0.003 0.002 9.49E-02
4.30E-09 -0.030 0.005 7.61E-10 0.000 0.002 8.73E-01
1.08E-08 -0.029 0.005 1.09E-09 0.001 0.002 5.48E-01
1.75E-08 0.034 0.005 3.61E-11 0.004 0.002 1.96E-02
1.82E-08 -0.029 0.005 2.57E-09 0.000 0.002 8.04E-01
3.35E-08 0.034 0.005 4.01E-12 0.006 0.002 3.91E-04
4.07E-08 0.027 0.005 1.35E-08 0.000 0.002 9.28E-01
4.44E-08 -0.027 0.005 3.19E-08 0.001 0.002 6.61E-01
7.02E-08 -0.035 0.006 3.58E-09 0.002 0.002 4.23E-01
7.30E-08 0.031 0.005 7.38E-11 0.005 0.002 4.22E-03
8.21E-08 -0.029 0.005 3.05E-09 0.002 0.002 2.73E-01
9.60E-08 -0.029 0.005 1.04E-08 0.001 0.002 5.90E-01
1.19E-07 0.031 0.005 1.02E-08 0.001 0.002 4.11E-01
1.32E-07 -0.029 0.005 2.87E-09 0.003 0.002 1.16E-01
1.39E-07 0.033 0.006 5.06E-09 0.002 0.002 2.15E-01
1.75E-07 -0.044 0.007 1.35E-10 0.007 0.002 2.51E-03
1.87E-07 0.031 0.005 7.55E-09 0.002 0.002 3.22E-01
1.88E-07 0.027 0.005 3.36E-08 0.001 0.002 7.15E-01
2.27E-07 -0.027 0.005 3.12E-08 0.001 0.002 6.46E-01
2.81E-07 0.028 0.005 1.00E-08 0.002 0.002 2.60E-01
3.09E-07 0.028 0.005 6.73E-09 0.002 0.002 1.68E-01
5.75E-07 0.052 0.009 2.74E-08 0.004 0.003 2.01E-01
7.05E-07 0.027 0.005 2.55E-08 0.002 0.002 1.58E-01
7.90E-07 -0.028 0.005 1.31E-08 0.003 0.002 8.82E-02
9.49E-07 -0.029 0.005 6.80E-09 0.003 0.002 4.49E-02
9.64E-07 -0.031 0.005 8.48E-09 0.004 0.002 3.70E-02
1.17E-06 0.033 0.006 2.38E-08 0.004 0.002 8.27E-02
1.84E-06 -0.051 0.009 2.51E-08 0.006 0.003 4.57E-02
2.81E-06 -0.028 0.005 4.68E-09 0.005 0.002 3.05E-03
2.88E-06 0.028 0.005 1.65E-08 0.004 0.002 1.29E-02
4.58E-06 -0.031 0.005 6.87E-09 0.006 0.002 1.11E-03
5.10E-06 -0.049 0.009 9.36E-09 0.009 0.003 3.37E-03
6.33E-06 -0.037 0.006 6.97E-10 0.009 0.002 1.15E-05
1.06E-05 0.031 0.006 2.43E-08 0.006 0.002 2.42E-03
p_adhd_adj b_adhd_unadse_adhd_unap_adhd_unadb_adhd_diff se_adhd_diff p_adhd_diff
4.31E-09 0.124 0.025 3.60E-07 0.011 0.010 0.272
3.81E-08 0.069 0.014 3.67E-07 0.001 0.006 0.843
4.23E-15 0.106 0.015 3.85E-13 0.002 0.006 0.768
1.23E-11 0.117 0.021 1.62E-08 0.016 0.009 0.091
1.84E-10 -0.074 0.013 3.14E-08 0.006 0.006 0.279
1.85E-08 -0.180 0.032 1.35E-08 0.011 0.014 0.404
8.95E-08 0.079 0.014 1.74E-08 0.008 0.006 0.160
1.73E-07 0.080 0.013 1.82E-09 0.014 0.006 0.012
5.17E-07 0.073 0.013 2.89E-08 0.011 0.006 0.060
1.70E-06 -0.115 0.020 7.68E-09 0.025 0.009 0.005
1.35E-05 -0.093 0.016 1.34E-08 0.026 0.007 0.000
9.75E-05 -0.077 0.014 1.58E-08 0.027 0.006 0.000
4.55E-04 -0.075 0.014 3.96E-08 0.030 0.006 0.000
p_aut_adj b_aut_unadj se_aut_unadjp_aut_unadj b_aut_diff se_aut_diff p_aut_diff
1.20E-09 0.084 0.015 1.07E-08 0.000 0.020 0.494
3.22E-07 -0.096 0.016 2.04E-09 -0.004 0.022 0.447
b_mdd_una se_mdd_unadp_mdd_unad b_bip_unadj se_bip_unadjp_bip_unadj b_adhd_unad
-0.001 0.006 8.96E-01 -0.052 0.016 9.04E-04 -0.061
-0.021 0.005 2.98E-05 0.038 0.014 6.28E-03 0.030
0.001 0.005 8.94E-01 0.037 0.014 7.93E-03 0.034
-0.007 0.006 2.49E-01 -0.049 0.017 4.74E-03 0.011
-0.002 0.005 6.44E-01 -0.019 0.014 1.73E-01 -0.058
0.002 0.005 6.51E-01 0.042 0.014 2.03E-03 0.023
0.008 0.005 1.21E-01 0.030 0.014 2.95E-02 0.021
0.009 0.006 1.09E-01 -0.029 0.015 5.63E-02 0.009
-0.007 0.005 1.80E-01 -0.036 0.013 8.00E-03 -0.004
-0.008 0.005 9.68E-02 -0.036 0.014 9.59E-03 -0.036
-0.007 0.007 3.44E-01 0.045 0.019 1.73E-02 0.015
-0.004 0.005 4.39E-01 0.018 0.014 1.73E-01 -0.013
-0.005 0.005 3.14E-01 -0.019 0.014 1.77E-01 -0.005
-0.004 0.005 4.16E-01 0.019 0.013 1.49E-01 -0.034
0.025 0.011 1.85E-02 -0.030 0.031 3.30E-01 0.053
-0.048 0.009 1.781E-08 -0.093 0.024 8.44E-05 0.022
-0.001 0.006 9.402E-01 0.012 0.017 4.72E-01 -0.019
0.012 0.005 1.333E-02 -0.012 0.014 3.89E-01 0.020
-0.008 0.005 9.646E-02 -0.026 0.014 6.46E-02 0.013
0.006 0.005 2.251E-01 0.021 0.014 1.44E-01 0.027
-0.004 0.007 5.462E-01 0.005 0.018 7.75E-01 -0.053
0.013 0.005 5.957E-03 0.037 0.014 6.05E-03 -0.010
0.005 0.006 3.560E-01 -0.032 0.015 3.49E-02 0.032
-0.006 0.005 2.297E-01 0.000 0.014 9.88E-01 -0.011
-0.009 0.009 3.103E-01 -0.055 0.026 3.29E-02 -0.017
0.004 0.006 4.913E-01 -0.011 0.017 5.09E-01 0.002
0.013 0.005 8.991E-03 0.026 0.014 5.87E-02 0.029
-0.015 0.007 2.654E-02 -0.023 0.018 2.03E-01 -0.042
0.022 0.005 7.027E-06 0.021 0.014 1.17E-01 0.019
-0.001 0.007 9.184E-01 0.015 0.021 4.87E-01 0.023
-0.014 0.005 6.512E-03 0.041 0.014 3.89E-03 -0.034
-0.034 0.009 6.645E-05 -0.081 0.024 6.45E-04 -0.049
-0.007 0.005 1.221E-01 0.010 0.013 4.76E-01 -0.027
0.005 0.006 3.963E-01 0.030 0.017 6.77E-02 0.040
0.034 0.005 4.006E-12 0.031 0.014 2.36E-02 0.043
0.012 0.005 1.458E-02 0.031 0.013 1.88E-02 -0.029
0.002 0.006 7.136E-01 -0.008 0.017 6.34E-01 -0.018
0.018 0.006 3.814E-03 0.017 0.017 3.12E-01 0.036
-0.003 0.005 6.216E-01 -0.004 0.014 7.94E-01 -0.002
0.001 0.005 8.281E-01 0.005 0.014 6.96E-01 -0.040
0.014 0.006 2.073E-02 0.063 0.017 2.10E-04 0.003
0.024 0.005 3.240E-06 0.001 0.015 9.21E-01 0.043
0.028 0.006 2.078E-06 0.035 0.016 2.79E-02 0.004
-0.004 0.005 4.192E-01 0.002 0.014 8.71E-01 -0.017
-0.022 0.005 2.388E-05 0.002 0.014 8.78E-01 -0.015
-0.023 0.005 1.824E-06 -0.024 0.014 7.40E-02 -0.012
-0.007 0.005 1.701E-01 -0.009 0.014 5.34E-01 0.013
0.004 0.005 4.753E-01 -0.019 0.014 1.83E-01 0.028
-0.012 0.005 1.466E-02 -0.027 0.014 4.67E-02 0.030
0.000 0.005 9.645E-01 0.001 0.014 9.48E-01 -0.014
0.007 0.006 2.328E-01 -0.014 0.016 3.58E-01 0.020
-0.016 0.005 1.002E-03 -0.067 0.014 8.44E-07 -0.007
0.001 0.005 8.327E-01 0.011 0.014 4.45E-01 0.011
0.001 0.005 7.741E-01 -0.006 0.013 6.49E-01 -0.003
0.013 0.005 1.109E-02 -0.063 0.014 3.38E-06 -0.001
0.004 0.006 4.755E-01 0.006 0.016 6.87E-01 -0.021
-0.005 0.006 4.140E-01 -0.018 0.016 2.60E-01 -0.005
0.004 0.006 5.089E-01 0.036 0.017 2.76E-02 0.010
-0.011 0.005 1.866E-02 0.024 0.014 7.17E-02 -0.013
0.000 0.007 9.538E-01 0.000 0.019 9.97E-01 -0.015
-0.008 0.005 9.360E-02 -0.041 0.015 5.96E-03 0.011
0.000 0.005 9.827E-01 -0.043 0.013 1.42E-03 -0.002
0.004 0.006 4.973E-01 -0.038 0.016 1.61E-02 -0.019
0.003 0.005 5.613E-01 0.002 0.014 8.81E-01 0.039
0.010 0.005 4.392E-02 0.036 0.014 1.10E-02 0.002
0.025 0.006 6.194E-06 0.032 0.016 3.63E-02 -0.001
0.013 0.005 1.286E-02 0.029 0.014 3.93E-02 0.043
-0.001 0.005 8.141E-01 -0.011 0.015 4.81E-01 -0.010
-0.002 0.005 7.088E-01 -0.026 0.015 7.58E-02 0.004
0.006 0.005 2.381E-01 -0.035 0.014 1.38E-02 -0.035
0.008 0.005 1.029E-01 0.028 0.014 5.09E-02 0.033
0.009 0.005 7.206E-02 0.020 0.014 1.61E-01 -0.023
0.029 0.006 2.652E-07 0.035 0.016 2.68E-02 0.012
-0.003 0.007 6.161E-01 -0.028 0.018 1.26E-01 0.021
-0.011 0.005 2.887E-02 0.029 0.014 3.09E-02 0.019
0.016 0.008 3.960E-02 0.023 0.022 2.91E-01 0.007
0.007 0.007 3.183E-01 -0.088 0.021 2.39E-05 0.020
0.001 0.006 8.396E-01 0.015 0.015 3.14E-01 -0.003
0.008 0.005 9.886E-02 0.059 0.014 3.17E-05 -0.001
0.007 0.008 3.722E-01 0.075 0.022 5.49E-04 0.033
0.010 0.005 3.290E-02 0.015 0.013 2.52E-01 0.005
0.020 0.005 3.392E-05 0.015 0.013 2.77E-01 0.025
0.010 0.005 4.959E-02 0.012 0.014 3.83E-01 0.023
-0.023 0.005 8.091E-06 -0.052 0.014 2.68E-04 -0.018
0.025 0.007 5.559E-04 0.034 0.020 9.97E-02 -0.017
0.007 0.006 2.030E-01 0.033 0.016 4.13E-02 0.042
-0.002 0.005 7.420E-01 -0.021 0.015 1.45E-01 -0.004
0.020 0.005 3.618E-05 0.028 0.014 4.19E-02 0.018
-0.014 0.005 6.005E-03 0.018 0.014 2.01E-01 -0.039
-0.025 0.005 4.895E-07 -0.048 0.014 6.96E-04 -0.020
0.007 0.005 1.748E-01 0.033 0.014 2.09E-02 0.079
-0.008 0.005 8.274E-02 -0.053 0.014 1.33E-04 -0.018
0.004 0.008 5.611E-01 0.022 0.021 3.05E-01 0.052
0.005 0.006 4.077E-01 -0.041 0.016 1.08E-02 0.017
-0.002 0.005 6.684E-01 -0.039 0.013 3.26E-03 -0.022
0.002 0.005 7.111E-01 0.030 0.013 2.36E-02 -0.038
-0.003 0.005 6.158E-01 -0.021 0.014 1.42E-01 0.000
-0.018 0.005 2.199E-04 -0.047 0.014 7.60E-04 -0.040
-0.002 0.007 7.479E-01 -0.037 0.018 4.47E-02 -0.039
-0.005 0.006 3.864E-01 0.020 0.018 2.52E-01 0.035
-0.015 0.005 2.895E-03 -0.037 0.014 8.24E-03 -0.016
0.000 0.005 9.840E-01 -0.044 0.014 2.32E-03 0.003
-0.001 0.005 8.197E-01 -0.029 0.014 3.71E-02 0.018
0.007 0.005 2.121E-01 -0.027 0.015 7.19E-02 -0.011
-0.009 0.005 7.845E-02 -0.031 0.014 3.09E-02 -0.008
-0.005 0.005 3.530E-01 0.049 0.014 5.01E-04 -0.016
0.009 0.006 1.665E-01 0.068 0.017 8.75E-05 0.013
0.002 0.005 6.236E-01 0.045 0.014 1.85E-03 0.005
0.003 0.006 6.178E-01 0.058 0.016 2.67E-04 0.015
0.015 0.005 4.842E-03 0.026 0.015 7.82E-02 0.005
0.011 0.005 2.991E-02 -0.058 0.014 2.14E-05 -0.005
-0.011 0.007 7.749E-02 -0.037 0.018 3.71E-02 0.026
-0.007 0.005 1.486E-01 -0.040 0.014 3.33E-03 -0.007
0.001 0.005 8.984E-01 -0.031 0.014 3.29E-02 -0.022
0.012 0.006 5.821E-02 0.049 0.017 3.36E-03 0.044
0.002 0.005 6.768E-01 -0.029 0.014 3.20E-02 -0.032
0.026 0.008 7.199E-04 0.063 0.023 5.83E-03 0.003
-0.002 0.005 6.389E-01 -0.045 0.014 1.77E-03 0.016
-0.010 0.006 8.187E-02 0.045 0.017 7.07E-03 0.004
0.011 0.006 3.824E-02 0.035 0.016 2.42E-02 -0.002
-0.004 0.005 4.287E-01 -0.046 0.014 6.51E-04 -0.012
-0.021 0.008 1.149E-02 -0.088 0.023 1.63E-04 0.030
-0.001 0.005 8.240E-01 -0.031 0.013 2.06E-02 -0.024
0.008 0.005 7.987E-02 0.040 0.014 2.65E-03 -0.023
0.002 0.006 7.320E-01 0.055 0.018 2.25E-03 -0.017
-0.009 0.008 2.959E-01 -0.053 0.023 2.37E-02 -0.102
0.012 0.005 1.475E-02 0.041 0.014 2.59E-03 -0.009
0.013 0.006 2.861E-02 0.060 0.017 3.40E-04 0.036
0.010 0.006 9.554E-02 0.059 0.016 3.03E-04 0.011
0.012 0.006 2.471E-02 0.050 0.015 1.16E-03 0.006
-0.009 0.005 6.844E-02 0.033 0.014 2.01E-02 0.020
0.010 0.005 3.773E-02 0.040 0.013 2.85E-03 0.000
-0.004 0.005 4.252E-01 -0.052 0.014 1.19E-04 -0.026
0.005 0.005 3.036E-01 -0.052 0.014 2.30E-04 0.016
0.014 0.005 9.316E-03 0.081 0.015 7.75E-08 -0.015
-0.010 0.007 1.127E-01 -0.089 0.018 1.07E-06 -0.013
-0.005 0.005 2.872E-01 0.081 0.014 6.44E-09 -0.024
-0.012 0.005 1.557E-02 -0.059 0.014 1.67E-05 -0.029
-0.007 0.005 2.013E-01 -0.067 0.015 4.54E-06 -0.018
0.028 0.008 3.286E-04 0.114 0.021 4.92E-08 0.055
b_mdd_una se_mdd_unadp_mdd_unad b_scz_unadj se_scz_unadj p_scz_unadj b_adhd_unad
0.003 0.005 4.95E-01 0.019 0.010 5.54E-02 0.008
0.004 0.005 4.94E-01 0.007 0.010 4.94E-01 -0.007
0.002 0.007 8.14E-01 0.002 0.012 8.61E-01 -0.007
-0.058 0.010 8.33E-10 -0.006 0.005 2.08E-01 0.023
0.032 0.014 2.24E-02 0.006 0.007 4.20E-01 -0.004
0.062 0.013 3.26E-06 -0.012 0.007 7.96E-02 0.013
-0.003 0.013 8.45E-01 -0.005 0.007 4.58E-01 0.042
0.010 0.010 3.29E-01 0.006 0.005 2.48E-01 0.016
0.023 0.010 2.10E-02 -0.001 0.005 8.07E-01 -0.005
0.046 0.010 7.44E-06 -0.007 0.005 1.98E-01 0.017
-0.027 0.010 4.70E-03 -0.009 0.005 6.41E-02 -0.002
-0.008 0.010 4.53E-01 -0.025 0.005 4.95E-07 -0.005
-0.055 0.016 3.81E-04 -0.013 0.008 9.92E-02 -0.064
0.039 0.010 4.96E-05 0.019 0.005 7.06E-05 -0.006
-0.060 0.010 3.48E-10 -0.010 0.005 3.57E-02 -0.005
0.060 0.011 1.31E-08 0.014 0.005 8.69E-03 -0.010
-0.046 0.016 3.10E-03 -0.013 0.008 9.46E-02 -0.017
-0.076 0.015 1.67E-07 -0.029 0.007 8.10E-05 -0.054
0.087 0.010 5.00E-18 0.016 0.005 1.67E-03 -0.005
b_scz_unadjse_scz_unadj p_scz_unadj b_bip_unadj se_bip_unadjp_bip_unadj b_adhd_unad
-0.043 0.010 1.99E-05 0.047 0.014 7.06E-04 0.034
-0.023 0.010 1.94E-02 0.011 0.014 4.19E-01 -0.051
0.011 0.012 3.27E-01 0.001 0.017 9.57E-01 0.017
0.007 0.010 5.05E-01 -0.026 0.014 6.15E-02 0.010
0.048 0.010 7.12E-07 0.008 0.014 5.60E-01 -0.016
-0.010 0.010 3.19E-01 0.031 0.013 1.94E-02 0.029
0.026 0.010 9.00E-03 0.008 0.014 5.44E-01 0.016
-0.006 0.010 5.25E-01 -0.014 0.013 2.83E-01 -0.008
-0.008 0.010 4.40E-01 0.001 0.014 9.66E-01 -0.019
-0.010 0.010 3.03E-01 0.003 0.014 8.27E-01 -0.006
0.039 0.010 1.36E-04 0.029 0.014 4.39E-02 0.009
-0.004 0.010 6.64E-01 -0.006 0.014 6.36E-01 -0.006
0.076 0.010 8.94E-15 0.031 0.014 2.36E-02 0.043
0.027 0.010 5.20E-03 -0.001 0.014 9.43E-01 0.003
0.050 0.010 3.67E-07 0.002 0.014 8.71E-01 -0.016
-0.032 0.012 8.70E-03 -0.015 0.017 3.78E-01 -0.037
0.028 0.009 3.00E-03 0.033 0.013 1.33E-02 0.057
-0.028 0.010 3.80E-03 -0.035 0.014 1.01E-02 -0.015
-0.002 0.010 8.47E-01 -0.010 0.014 4.93E-01 -0.007
0.026 0.011 1.53E-02 0.017 0.015 2.40E-01 0.001
0.002 0.010 8.57E-01 -0.029 0.014 3.18E-02 -0.016
-0.012 0.011 2.72E-01 0.018 0.016 2.69E-01 -0.007
-0.134 0.014 2.90E-22 -0.067 0.019 4.86E-04 -0.005
0.064 0.011 1.58E-09 0.024 0.016 1.26E-01 0.001
0.009 0.010 3.82E-01 0.047 0.014 5.48E-04 -0.025
-0.030 0.010 2.40E-03 0.002 0.014 8.96E-01 -0.013
0.005 0.010 5.95E-01 0.026 0.014 6.20E-02 -0.009
0.030 0.010 1.80E-03 0.009 0.014 4.88E-01 0.016
0.013 0.018 4.70E-01 0.017 0.025 5.00E-01 0.019
0.016 0.010 9.29E-02 0.014 0.014 3.06E-01 0.000
-0.014 0.010 1.62E-01 -0.024 0.014 7.64E-02 -0.012
0.009 0.010 3.86E-01 -0.024 0.014 8.98E-02 -0.034
-0.022 0.010 3.53E-02 -0.017 0.015 2.39E-01 -0.024
0.011 0.012 3.60E-01 0.024 0.017 1.42E-01 0.023
-0.042 0.017 1.27E-02 -0.034 0.025 1.70E-01 -0.032
-0.066 0.010 3.05E-12 -0.037 0.013 5.89E-03 -0.023
0.041 0.010 2.70E-05 0.017 0.014 1.99E-01 0.028
-0.024 0.010 2.07E-02 -0.049 0.014 6.36E-04 -0.040
0.015 0.018 3.94E-01 -0.070 0.024 4.09E-03 -0.021
-0.057 0.012 2.97E-06 -0.045 0.017 7.56E-03 -0.085
-0.013 0.011 2.38E-01 0.049 0.015 1.13E-03 0.020
b_mdd_una se_mdd_unadp_mdd_unad b_scz_unadj se_scz_unadj p_scz_unadj b_bip_unadj
0.020 0.009 2.30E-02 -0.010 0.026 6.85E-01 0.035
0.003 0.005 5.06E-01 0.004 0.014 7.42E-01 0.029
0.007 0.005 1.74E-01 0.042 0.010 6.51E-05 0.030
0.012 0.008 1.27E-01 0.007 0.015 6.33E-01 -0.022
-0.010 0.005 4.51E-02 0.000 0.010 9.92E-01 -0.011
-0.014 0.012 2.48E-01 -0.111 0.023 1.96E-06 -0.124
0.010 0.005 3.80E-02 -0.013 0.010 1.91E-01 0.012
0.007 0.005 1.28E-01 -0.016 0.010 8.71E-02 0.003
0.013 0.005 8.15E-03 0.017 0.010 6.90E-02 0.019
-0.002 0.008 8.35E-01 0.005 0.015 7.34E-01 0.028
-0.027 0.006 2.47E-06 -0.045 0.012 1.23E-04 -0.042
0.009 0.005 5.62E-02 -0.005 0.010 5.78E-01 0.008
0.001 0.005 8.65E-01 0.016 0.010 1.09E-01 -0.015
se_mdd_unap_mdd_unad b_scz_unadj se_scz_unadj p_scz_unadj b_bip_unadj se_bip_unadj
0.005 9.34E-01 0.007 0.010 5.10E-01 -0.014 0.014
0.006 0.5195 -0.032 0.011 3.90E-03 -0.003 0.016
se_adhd_unap_adhd_unadb_aut_unadj se_aut_unadjp_aut_unadj nearestGene
0.016 1.34E-04 0.016 0.016 3.08E-01 WSCD2
0.014 3.05E-02 -0.015 0.014 2.90E-01 ARFGEF2
0.014 1.45E-02 0.038 0.015 8.72E-03 CREB5
0.018 5.31E-01 0.038 0.018 3.21E-02 KLF16
0.013 9.76E-06 -0.029 0.014 3.44E-02 CALN1
0.013 8.53E-02 -0.015 0.014 2.94E-01 RP11-467I7.1
0.013 1.21E-01 -0.004 0.014 7.91E-01 RPS18P6
0.015 5.32E-01 0.036 0.016 2.30E-02 GDNF
0.013 7.63E-01 0.018 0.014 1.89E-01 DIP2C
0.013 7.89E-03 -0.030 0.014 3.12E-02 TACC1
0.017 3.99E-01 -0.019 0.019 3.11E-01 RP11-160H22.3
0.014 3.27E-01 0.022 0.014 1.21E-01 MSL2
0.014 7.20E-01 -0.022 0.015 1.27E-01 ARL14EP
0.014 1.36E-02 -0.047 0.014 8.06E-04 SRPK2
0.029 6.22E-02 -0.027 0.029 3.63E-01 CCDC175
0.022 0.326 -0.035 0.023 1.29E-01 ZSCAN23
0.017 0.242 0.040 0.017 2.20E-02 MIR137HG
0.014 0.150 0.002 0.014 8.59E-01 ATP2A2
0.014 0.374 -0.001 0.015 9.31E-01 PPP1R16B
0.014 0.053 0.047 0.015 1.31E-03 NRGN
0.018 0.004 -0.029 0.019 1.21E-01 GULOP
0.013 0.469 0.008 0.014 5.90E-01 TSNARE1
0.016 0.036 0.010 0.016 5.58E-01 MPHOSPH9
0.014 0.421 0.017 0.014 2.20E-01 STAG1
0.029 0.565 -0.061 0.029 3.44E-02 SLC39A8
0.017 0.888 0.013 0.017 4.69E-01 FXR1
0.014 0.040 0.031 0.014 3.05E-02 TCF20
0.018 0.017 -0.031 0.018 9.42E-02 DGKZ
0.013 0.161 0.005 0.014 7.17E-01 CTD-2171N6.1
0.019 0.240 0.033 0.020 9.65E-02 MEF2C-AS1
0.014 0.015 -0.033 0.015 2.19E-02 GIGYF2
0.023 0.030 0.000 0.024 9.97E-01 NT5C2
0.013 0.043 0.015 0.014 2.73E-01 NA
0.017 0.017 0.006 0.017 7.36E-01 IGSF9B
0.014 0.001 0.026 0.014 7.23E-02 RP4-598G3.1
0.013 0.028 0.027 0.014 5.18E-02 SYNGAP1
0.016 0.279 -0.001 0.017 9.43E-01 CSMD1
0.016 0.025 0.024 0.017 1.43E-01 GPM6A
0.015 0.903 0.011 0.015 4.47E-01 FHIT
0.014 0.004 -0.036 0.014 9.87E-03 FOXP1
0.017 0.839 -0.005 0.018 7.80E-01 FTCDNL1
0.014 0.002 0.037 0.015 1.16E-02 TMX2:TMX2-CTNND1
0.016 0.791 0.025 0.016 1.16E-01 ENSG00000231993
0.014 0.222 -0.001 0.014 9.51E-01 ENSG00000259864
0.014 0.282 0.011 0.015 4.48E-01 RERE
0.013 0.376 -0.011 0.014 4.43E-01 VRK2
0.014 0.363 0.022 0.015 1.35E-01 ENSG00000258028
0.014 0.045 0.009 0.015 5.36E-01 IMMP2L
0.014 0.026 0.009 0.014 5.34E-01 ENSG00000230407
0.014 0.331 0.024 0.015 9.83E-02 PCNXL3
0.016 0.204 0.023 0.016 1.59E-01 ZNF536
0.014 0.611 0.030 0.014 3.59E-02 CACNA1C
0.013 0.402 0.011 0.014 4.45E-01 OPCML
0.013 0.805 -0.001 0.014 9.48E-01 ENSG00000207252
0.013 0.939 -0.002 0.014 8.63E-01 MAD1L1
0.016 0.176 0.028 0.016 9.06E-02 AIG1
0.016 0.773 0.000 0.017 9.88E-01 AKT3
0.016 0.557 0.038 0.017 2.36E-02 ENSG00000253107
0.014 0.321 0.004 0.014 7.96E-01 ENSG00000253413
0.019 0.415 -0.008 0.020 6.68E-01 ENSG00000237954
0.015 0.449 -0.047 0.015 1.27E-03 RFT1
0.013 0.859 0.032 0.014 2.26E-02 ZSWIM6
0.016 0.216 -0.018 0.016 2.80E-01 CHRNA3
0.014 0.005 0.026 0.014 6.87E-02 PDE4B
0.014 0.875 -0.014 0.015 3.32E-01 CACNA1I
0.015 0.937 0.034 0.016 3.37E-02 RGS6
0.014 0.002 0.050 0.015 5.61E-04 SRPK2
0.015 0.492 -0.014 0.016 3.82E-01 RP3-399L15.3
0.014 0.801 -0.007 0.014 6.02E-01 SMG6
0.014 0.010 -0.027 0.014 5.55E-02 GATAD2A
0.014 0.022 0.017 0.015 2.62E-01 ENSG00000235377
0.014 0.099 0.026 0.015 6.98E-02 RFPL4AP3
0.016 0.448 0.057 0.017 5.67E-04 ENSG00000262267
0.018 0.246 -0.026 0.019 1.60E-01 ENSG00000233263
0.013 0.148 0.000 0.014 9.76E-01 ENSG00000254842
0.021 0.735 -0.031 0.022 1.52E-01 ASCL1
0.020 0.314 -0.030 0.021 1.57E-01 GRM3
0.015 0.845 -0.005 0.016 7.39E-01 SOX5
0.014 0.924 0.026 0.014 7.28E-02 PPP1R13B
0.021 0.116 0.051 0.022 2.17E-02 CACNB2
0.013 0.701 0.030 0.014 2.90E-02 CLCN3
0.013 0.059 0.006 0.014 6.67E-01 ENSG00000259503
0.014 0.112 0.001 0.015 9.37E-01 ENSG00000259221
0.014 0.211 -0.021 0.015 1.48E-01 SF3B1
0.021 0.410 0.032 0.021 1.32E-01 ENSG00000224968
0.016 0.009 0.028 0.016 8.27E-02 PRKD1
0.015 0.768 -0.013 0.015 3.88E-01 MRPS11P1
0.014 0.198 0.045 0.014 1.60E-03 AC003088.1
0.014 0.007 -0.034 0.015 1.88E-02 RAI1
0.014 0.164 0.006 0.015 6.54E-01 DRD2
0.014 0.000 0.010 0.015 4.92E-01 PTPRF
0.013 0.169 -0.033 0.014 1.86E-02 TMEM219
0.021 0.013 0.028 0.022 2.06E-01 LINC00606
0.016 0.259 -0.002 0.016 8.95E-01 STAT6
0.013 0.098 -0.032 0.014 2.13E-02 AC091969.1
0.013 0.004 -0.012 0.014 4.01E-01 ENSG00000259616
0.014 0.982 0.006 0.014 6.66E-01 ENSG00000258224
0.014 0.004 -0.015 0.014 2.91E-01 FURIN
0.018 0.026 0.002 0.019 9.18E-01 GABBR2
0.018 0.058 0.002 0.019 9.26E-01 ENSG00000221237
0.014 0.249 -0.026 0.015 7.58E-02 RIMS1
0.014 0.813 -0.002 0.015 8.89E-01 HCN1
0.014 0.187 -0.011 0.014 4.60E-01 ENSG00000240354
0.015 0.449 0.006 0.016 6.90E-01 MMP16
0.015 0.566 -0.019 0.015 2.09E-01 ENSG00000258144
0.014 0.259 0.030 0.015 4.19E-02 DGKI
0.018 0.457 0.006 0.018 7.36E-01 CNTN4
0.014 0.728 0.023 0.015 1.26E-01 ATXN7
0.015 0.326 0.001 0.016 9.46E-01 RP11-111I12.1
0.015 0.731 -0.006 0.015 7.07E-01 RP11-284M14.1
0.013 0.708 -0.009 0.014 5.01E-01 SNAP91
0.018 0.153 0.018 0.019 3.28E-01 PLA2G15
0.014 0.590 -0.006 0.014 6.92E-01 CPEB1
0.014 0.114 0.037 0.015 1.22E-02 CUL3
0.016 0.007 0.037 0.017 3.22E-02 HNRNPA1P46
0.014 0.017 -0.047 0.014 9.30E-04 ENSG00000229271
0.021 0.903 0.018 0.022 4.18E-01 MKL1
0.014 0.257 0.006 0.015 6.98E-01 ZEB2
0.016 0.786 0.004 0.016 8.06E-01 NOSIP:PRRG2
0.015 0.883 -0.012 0.015 4.24E-01 EMX1
0.014 0.381 0.015 0.014 2.77E-01 CNOT1
0.024 0.210 -0.030 0.024 2.24E-01 ENSG00000227854
0.013 0.066 0.009 0.014 5.00E-01 PSD3
0.014 0.095 -0.023 0.014 9.50E-02 ZNF804A
0.017 0.315 0.004 0.018 8.49E-01 BNIP3L
0.023 0.000 -0.015 0.024 5.51E-01 ENSG00000253108
0.014 0.491 -0.006 0.014 6.89E-01 RBM26
0.016 0.021 0.044 0.017 7.30E-03 WHSC1L1
0.016 0.493 0.012 0.017 4.61E-01 ALMS1
0.016 0.692 0.016 0.016 3.06E-01 ENSG00000261038
0.014 0.136 -0.040 0.015 5.36E-03 MSRA
0.013 0.996 0.016 0.014 2.35E-01 RPTOR
0.013 0.053 -0.018 0.014 1.97E-01 ETF1
0.014 0.230 -0.003 0.014 8.48E-01 ENSG00000255545
0.015 0.290 0.050 0.015 1.12E-03 SEC11A
0.018 0.476 0.029 0.018 1.18E-01 VPS45
0.014 0.085 -0.007 0.014 6.13E-01 TRANK1
0.014 0.037 -0.012 0.014 3.72E-01 BCL11B
0.015 0.209 -0.024 0.015 1.14E-01 GRIN2A
0.022 0.011 0.058 0.022 9.67E-03 MPP6
se_adhd_unap_adhd_unadb_aut_unadj se_aut_unadjp_aut_unadj nearestGene
0.014 5.51E-01 -0.039 0.014 6.05E-03 ELAVL2
0.014 6.08E-01 -0.010 0.015 5.10E-01 SSBP2
0.018 6.89E-01 -0.031 0.019 9.76E-02 ADD3
0.013 8.50E-02 0.013 0.014 3.59E-01 TRANK1
0.019 8.43E-01 0.051 0.020 9.11E-03 TENM4
0.019 4.82E-01 0.027 0.020 1.64E-01 NCAN
0.018 1.76E-02 0.032 0.018 8.12E-02 ENSG00000249568
0.014 2.57E-01 -0.007 0.014 6.22E-01 HLF
0.014 7.08E-01 0.013 0.014 3.51E-01 JADE2
0.014 2.22E-01 0.026 0.015 7.69E-02 LMAN2L
0.014 8.97E-01 -0.018 0.014 1.96E-01 RPS6KA2
0.014 7.03E-01 0.008 0.014 6.04E-01 FADS2
0.021 2.31E-03 -0.067 0.022 1.95E-03 TFAP2B
0.014 6.61E-01 0.010 0.014 4.63E-01 SLC25A17
0.013 6.79E-01 -0.042 0.014 2.60E-03 ITIH1
0.014 5.06E-01 0.051 0.015 7.29E-04 ZSCAN2
0.022 4.39E-01 0.033 0.023 1.50E-01 AC003088.1
0.021 1.09E-02 -0.053 0.022 1.55E-02 DFNA5
0.014 7.44E-01 -0.025 0.015 8.50E-02 CACNA1C-IT3
se_adhd_unap_adhd_unadb_aut_unadj se_aut_unadjp_aut_unadj nearestGene
0.014 1.48E-02 -0.019 0.015 1.98E-01 STAU1
0.014 1.90E-04 -0.003 0.014 8.03E-01 MEF2C
0.017 3.10E-01 0.058 0.017 6.59E-04 RCN1
0.014 4.90E-01 -0.009 0.014 5.22E-01 CARM1P1
0.014 2.48E-01 -0.021 0.014 1.41E-01 RERE
0.013 2.91E-02 0.032 0.0141 2.18E-02 OLFM4
0.014 2.44E-01 0.036 0.0142 1.04E-02 RPL31P12
0.013 5.39E-01 0.014 0.014 3.15E-01 ENSG00000259434
0.013 1.51E-01 -0.026 0.014 6.74E-02 ESR2:SYNE2
0.014 6.52E-01 0.013 0.014 3.69E-01 CTC-340A15.2
0.014 5.16E-01 -0.004 0.0148 7.78E-01 TCF4
0.014 6.75E-01 -0.013 0.014 3.46E-01 LRFN5
0.014 1.49E-03 0.026 0.0143 7.23E-02 RP4-598G3.1
0.013 8.36E-01 0.007 0.0139 6.22E-01 ENSG00000234273
0.014 2.54E-01 -0.021 0.0141 1.36E-01 RERE
0.017 2.71E-02 -0.060 0.0176 6.59E-04 BEND4
0.013 1.63E-05 0.062 0.0139 7.48E-06 RP11-6N13.1
0.014 2.86E-01 -0.056 0.0142 8.49E-05 RNU7-160P
0.014 6.06E-01 -0.011 0.0144 4.67E-01 RNU6-695P
0.015 9.26E-01 0.011 0.0153 4.86E-01 ENSG00000266033
0.013 2.30E-01 -0.025 0.014 7.67E-02 RSRC1
0.015 6.22E-01 -0.031 0.0161 5.80E-02 ENSG00000230365
0.019 7.77E-01 -0.025 0.0197 2.06E-01 PGBD1
0.015 9.60E-01 0.024 0.0155 1.20E-01 L3MBTL2
0.014 6.86E-02 0.035 0.0142 1.31E-02 PMFBP1
0.014 3.37E-01 -0.010 0.0144 4.78E-01 SOX5
0.014 4.89E-01 -0.005 0.0143 7.22E-01 RBFOX1
0.013 2.36E-01 0.004 0.0141 7.50E-01 RPS6KL1
0.024 4.33E-01 -0.014 0.0253 5.87E-01 DENND1A
0.013 9.76E-01 -0.017 0.014 2.16E-01 TMEM106B
0.014 3.91E-01 -0.008 0.0144 5.53E-01 LINC00669
0.014 1.33E-02 -0.025 0.0143 7.84E-02 TENM2
0.015 1.02E-01 0.000 0.0153 9.94E-01 ASTN2
0.017 1.67E-01 0.012 0.0174 4.84E-01 NR4A2
0.025 1.88E-01 -0.002 0.0271 9.35E-01 ENOX1
0.013 7.85E-02 -0.024 0.014 8.48E-02 ENSG00000271615
0.013 3.44E-02 0.005 0.0139 7.09E-01 DCC
0.015 6.30E-03 -0.042 0.015 5.62E-03 ENSG00000260411
0.024 3.72E-01 0.018 0.0252 4.65E-01 MYO18A
0.017 2.96E-07 -0.051 0.017 2.86E-03 SORCS3
0.015 2.01E-01 0.003 0.0159 8.61E-01 SHISA9
se_bip_unadjp_bip_unadj b_aut_unadj se_aut_unadjp_aut_unadj nearestGene
0.017 4.69E-02 -0.033 0.024 1.69E-01 TFAP2D
0.010 3.60E-03 -0.003 0.014 8.11E-01 ENSG00000270234
0.015 4.32E-02 -0.002 0.015 8.73E-01 ST3GAL3
0.022 3.13E-01 -0.045 0.023 4.84E-02 SPAG16
0.013 4.00E-01 0.015 0.014 2.60E-01 SEMA6D
0.033 1.93E-04 -0.042 0.033 2.12E-01 ENSG00000253108
0.014 3.84E-01 0.020 0.014 1.55E-01 RNU6-815P
0.013 8.09E-01 0.035 0.014 1.25E-02 ENSG00000271327
0.014 1.59E-01 0.026 0.014 5.78E-02 FOXP2
0.022 2.09E-01 -0.057 0.021 7.26E-03 AC004158.2
0.016 9.85E-03 -0.063 0.017 1.46E-04 SORCS3
0.014 5.70E-01 -0.067 0.014 1.92E-06 LINC00461
0.014 2.92E-01 -0.077 0.015 1.14E-07 EEF1A1P11
p_bip_unadj b_adhd_unadse_adhd_unap_adhd_unadnearestGene
3.31E-01 -0.001 0.015 9.23E-01 SOX7
8.29E-01 -0.054 0.015 3.58E-04 ZNF877P
